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Open access under CC BYChemical analysis of up to 49 harmful and potentially harmful constituents (HPHC) in mainstream smoke,
in vitro cytotoxicity of the particulate and gas/vapor phase of mainstream smoke determined in the Neu-
tral Red Uptake assay, and in vitro bacterial mutagenicity of the particulate phase determined in the Sal-
monella typhimurium Reverse Mutation (Ames) assay are reported for three Electrically Heated Cigarette
Smoking System (EHCSS) series-K cigarettes, the University of Kentucky Reference Cigarette 2R4F, and a
number of comparator commercial conventional lit-end cigarettes (CC) under ISO machine-smoking con-
ditions and a total of 25 additional smoking regimens reﬂecting ‘human pufﬁng behavior’ (HPB). The
smoking machines were set to deliver nicotine yields for the EHCSS and comparator CC derived from
the 10th percentile to the 90th percentile of nicotine uptake distributions in smokers determined in
two clinical studies. Duplication of the smoking intensity ‘per cigarette’ on a smoking machine may pro-
vide an insight into product performance that is directly relevant to obtaining scientiﬁc evidence for
reduced exposure substantiation based on mainstream cigarette smoke HPHC-to-nicotine regressions.
The reported data support an overall evaluation of reduced exposure to HPHC and biological activity.
 2012 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
In the U.S., the enactment of the Family Smoking Prevention and
Tobacco Control Act (FSPTCA) (Family Smoking Prevention and To-
bacco Control Act, 2009) has empowered the U.S. Food and Drug
Administration (FDA) to evaluate and regulate Modiﬁed Risk
Tobacco Products (MRTPs) (Deyton et al., 2010) and to issue guid-
ance or regulations on the scientiﬁc evidence required for the
assessment and ongoing review of MRTPs (Food and Drug Admin-
istration, 2012). Additional guidance has been developed by the
Institute of Medicine (IOM) who have proposed novel testing strat-
egy approaches (Institute of Medicine, 2012). The following studies
were performed prior to the FDA guidance.
Results from in vitro and in vivo testing performed on various
Electrically Heated Cigarette Smoking System (EHCSS) prototypes
and test market versions of the EHCSS have been published that
document the basic product construction and an earlier testing
strategy (Patskan and Reininghaus, 2003), the smoke constituentchorp).
-NC-ND license.analysis (Roemer et al., 2008; Stabbert et al., 2003a; Werley
et al., 2008), in vitro testing (Roemer et al., 2008; Schramke et al.,
2006; Tewes et al., 2003; Werley et al., 2008), and in vivo testing
(Moennikes et al., 2008; Terpstra et al., 2003). Further publications
document additional testing on the generation of environmental
tobacco smoke (ETS) (Frost-Pineda et al., 2008a; Tricker et al.,
2009) and clinical evaluations (Feng et al., 2006; Frost-Pineda
et al., 2008b,c; Oey et al., 2003; Roethig et al., 2002, 2005, 2007,
2008; Unverdorben et al., 2005a,b, 2007, 2008).
In previous studies, the assays and methods selected to deter-
mine the pre-clinical hazard proﬁle of EHCSS series-K cigarettes in-
cluded chemical analysis of HPHC, cytotoxicity testing in the
Neutral Red Uptake (NRU) assay, mutagenicity testing in the Sal-
monella typhimurium Reverse Mutation assay and the Mouse Lym-
phoma Thymidine Kinase assay, mouse dermal tumorigenicity
testing in the Mouse Skin Painting assay, in vivo genotoxicity test-
ing in a 4-day Rat Erythrocyte Micronucleus study, testing for
pulmonary inﬂammation in a 35-day inhalation study in rats,
and subchronic exposure in a 90-day nose-only inhalation study
in rats. Cigarettes were smoked under International Organization
for Standardization (ISO) smoking conditions and one alternative
pufﬁng condition (Werley et al., 2008).
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versions of EHCSS series-K cigarettes have been investigated in
pre-clinical studies presented in this publication, in clinical trials
(Martin Leroy et al., 2012; Tricker et al., 2012a,b,c,d), and in a mod-
eling approach termed ‘nicotine bridging’ (Urban et al., 2012). This
paper presents the analytical chemistry, cytotoxicity, and bacterial
mutagenicity results for the EHCSS series-K and commercial con-
ventional lit-end cigarettes (CC) smoked under ISO smoking condi-
tions (International Organization for Standardization, 2000a), as
well as under a variety of smoking regimens reﬂecting human puff-
ing behavior (HPB) conditions (Table 1).
HPB conditions are used because no single machine-smoking
protocol can reﬂect human pufﬁng parameters (Bobak et al.,
2000; Bridges et al., 1986, 1990a,b; Gori and Lynch, 1985; Kolonen
et al., 1991; Moody, 1980; Nil and Baettig, 1989; Woodman et al.,
1987; Zacny and Stitzer, 1988). Because it is important to consider
not only the average but also the variance in smoking behavior, a
total of 25 HPB conditions, based on human smoking topography
data and nicotine uptake distributions obtained in two clinical
studies (Tricker et al., 2012a,c), were applied. This extended testing
strategy for evaluation of reduced exposure enables a rigorous
examination of the relative product performance and represents
one necessary step in reduced exposure substantiation in a trans-
lational fashion – from ‘product’ to ‘smoker’ to ‘population’. The
investigation of the impact of different pufﬁng intensities on the
delivery of HPHC, and in particular their relationship to nicotine,
allows for a better understanding of the product performance in
real life situations, i.e., different pufﬁng intensities and smoke in-
take, and enables predictions of exposure based on measured nic-
otine uptake distributions in smokers (Urban et al., 2012).2. Material and methods
2.1. Study design
In the ﬁrst part of this study, the delivery of HPHC and the tox-
icological activity of mainstream smoke (particulate phase and gas/Table 1
Smoking machine settings based on Human Pufﬁng Behavior, for EHCSS series-K and
conventional lit-end cigarettes.
Cigarette Smoking
condition
Puff volume
[ml]
Puff duration
[s]
Puff frequency
[min1]
EHCSS-K6 LOW4 40 1.2 4.0
MED1 78 1.8 1.0
MED2L 78 1.0 2.0
MED2U 78 2.6 2.0
MED4 78 1.8 4.0
HIGH1 126 2.6 1.0
HIGH2L 126 1.8 2.0
HIGH2U 126 3.4 2.0
EXTREME 126 3.8 2.0
EHCSS-K3 LOW 40 1.2 2.0
MED 78 1.8 2.0
HIGH 126 2.6 2.0
EXTREME 126 3.7 2.0
M6UK LOW 26 0.8 1.9
MED 50 1.4 1.7
HIGH 66 1.7 2.0
M6J LOW 15 0.7 0.9
MED 39 1.1 1.0
HIGH 55 1.5 1.2
PM1 LOW 29 0.9 3.6
MED 50 1.4 3.4
HIGH 64 1.6 4.0
Lark1 LOW 29 0.9 3.0
MED 42 1.2 2.5
HIGH 62 1.6 2.6vapor phase) from both EHCSS series-K cigarettes and CC smoked
under ISO conditions were determined. In vitro cytotoxicity was as-
sessed in the NRU assay and in vitro bacterial mutagenicity in the
S. typhimurium Reverse Mutation (Ames) assay. In the second part
of this study, the impact of different pufﬁng intensities was
investigated.
The studies were conducted in compliance with Good Labora-
tory Practice principles (Organization for Economic Co-operation
and Development, 1987) using validated assays and methods and
in-house quality assurance (Good Laboratory Practice Principles
of Gemany, 1994; International Conference on Harmonization,
1996). Concomitant testing of the Kentucky Reference Cigarette
2R4F (Kentucky Tobacco Research and Development Center,
2003) and positive control substances enabled comparison with
the historical databases to ensure commensurate assay and meth-
od performance.
2.2. Test and comparator cigarettes
Test cigarettes evaluated were the three versions of the EHCSS
series-K, namely the EHCSS-K6, the EHCSS-K6M, and the EHCSS-
K3. The EHCSS-K6M represents a mentholated equivalent to the
EHCSS-K6, while the EHCSS-K3 uses amore efﬁcient ﬁlter to further
reduce HPHC delivery. Further details are presented in Part 1 of the
EHCSS series-K evaluations (Schorp et al., 2012). Four comparator
CC were selected to match ISO tar delivery of the EHCSS series-K
cigarettes, or the lowest ISO delivery of selected markets: 6 mg
ISO tar delivery for U.K.marketMarlboro (M6UK) and Japanesemar-
ket Marlboro (M6J), and 1 mg ISO tar delivery for Philip Morris One
(PM1) and Lark One (Lark1). Both M6J and Lark1 contain a carbon
ﬁlter, which is typical for the Japanese market. The ISO tar, nicotine
and carbon monoxide yields (International Organization for Stan-
dardization, 1991, 1995a,b, 2000a,b,c) obtained on a linear smoking
machine are presented in Schorp et al. (2012).
The University of Kentucky Reference Cigarette 2R4F smoked
under ISO conditions served as internal control.
2.3. Smoking regimens
In addition to ISO conditions (International Organization for
Standardization, 2000a), cigarettes were also smoked under a vari-
ety of HPB conditions (Table 1) in order to obtain data for HPHC-to-
nicotine regressions. The HPB protocols for each of the four CC
were derived following the modeling approach by Urban et al.
(2008). Basically, these smoking protocols take into account the
normal distribution of the puff volumes (taken from human smok-
ing behavior data), i.e., on the 10th percentile, the mean, and the
90th percentile, and other parameters, such as puff duration and
puff frequency (for details see Urban et al., 2008), and are validated
based on 10th percentile, the mean, and the 90th percentile of nic-
otine uptake distribution from two clinical studies (Tricker et al.,
2012a,c). Concordance between the 10th, mean, and 90th percen-
tile of nicotine uptake distributions in humans and measured nic-
otine yields from smoking machines was achieved by iterative
modeling of pufﬁng parameters.
Because the modeling approach reported by Urban et al. (2008)
applies to CC, an alternative approach was applied for the EHCSS
series-K cigarettes. Additional protocols were based on the 10th
percentile, the mean, and the 90th percentile of the puff volume
distribution (same approach as for CC). However, owing to the fact
that little information on smoke yields under a range of different
pufﬁng conditions is available for the EHCSS, 13 HPB protocols
were selected for the EHCSS series-K cigarettes (Table 1), and val-
idated based on the 10th percentile, the mean, and the 90th per-
centile of nicotine uptake distribution from a clinical study
(Tricker et al., 2012a).
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The cigarettes were conditioned according to the ISO 3402 stan-
dard protocol (International Organization for Standardization,
1991). Both, the CC and the EHCSS series-K were smoked on a
20-port rotary smoking machine, operating in basic conformity
with the ISO standard (International Organization for Standardiza-
tion, 2000a). The puff count for the EHCSS was restricted to 8 puffs
(Werley et al., 2008). Using a linear smoking machine a higher ‘tar’
delivery is obtained under ISO conditions (International Organiza-
tion for Standardization, 2000b) as reported by Schorp et al. (2012).
The total particulate matter (TPM) representing the particulate
phase of cigarette mainstream smoke was collected on a glass ﬁber
ﬁlter (Cambridge ﬁlter) and extracted with dimethyl sulfoxide
(DMSO) for its application in the NRU and Ames assay. The gas/va-
por phase that passed through the glass ﬁber ﬁlter was bubbled
through an impinger containing ice-cold phosphate-buffered sal-
ine, thus trapping the water-soluble gas/vapor phase (GVP) portion
of the mainstream smoke that was applied in the NRU assay only.
2.5. Smoke chemistry
As part of an overall toxicological evaluation, chemical analysis
was performed for up to 49 HPHC as reported previously (Werley
et al., 2008). References for the list of analyzed HPHC included the
US Consumer Product Safety Commission (US Consumer Product
Safety Commission in Consultation with the U.S. Department of
Health and Human Services, 1993) and the International Agency
for Research on Cancer (International Agency for Research on Can-
cer, 1986). The HPHC analyzed represent various chemical classes
from both the TPM and GVP of cigarette mainstream smoke. Vola-
tile N-nitrosamines (N-nitrosodimethylamine, N-nitrosoethyl-
methylamine, N-nitrosodiethylamine, N-nitrosodi-n-propylamine,
N-nitrosodi-n-butylamine, N-nitrosopyrrolidine, N-nitrosopiperi-
dine) were not determined since preliminary experiments have
shown that they are not detectable for the EHCSS series-K ciga-
rettes, even when smoked under the most intense HPB conditions.
In general, four replicate samples were generated for each cigarette
type, and 10–20 cigarettes were smoked for each sample.
TPM was determined gravimetrically from glass ﬁber ﬁlters
according to ISO standard 4387 (International Organization for
Standardization, 2000b).
Nicotine was determined according to ISO standard 10315
(International Organization for Standardization, 2000c). Essen-
tially, a TPM-loaded glass ﬁber ﬁlter was extracted with 2-propa-
nol containing triethylamine. Isoquinoline was added as an
internal standard, and nicotine was determined by gas chromatog-
raphy (GC) with a nitrogen phosphorous or ﬂame ionization
detector.
Water was determined from the 2-propanol extract from the
TPM-loaded glass ﬁber ﬁlter using Karl Fischer titration according
to ISO standard 10362-2 (International Organization for Standard-
ization, 1995a).
Carbon monoxide was analyzed by non-dispersive infrared pho-
tometry according to ISO standard 8454 (International Organiza-
tion for Standardization, 1995b). Nitrogen oxides were
determined by chemoluminescence after reaction with ozone. Car-
bon monoxide and nitrogen oxides were measured simultaneously
by connecting the gas monitors in series. For calibration, certiﬁed
reference gases were used.
Aldehydes (formaldehyde, acetaldehyde, acrolein, propionalde-
hyde, and crotonaldehyde) were trapped using two impingers
connected in series, each containing acidiﬁed 2,4-dinitrophenylhy-
drazine solution (DNPH) in acetonitrile. The derivatized aldehydes
were stabilized by adding pyridine. The DNPH derivatives were
quantiﬁed using reversed-phase liquid chromatography (LC) andphotometric detection (Hsu et al., 1999). For crotonaldehyde, a
separate chromatographic run was performed.
The aliphatic dienes 1,3-butadiene and isoprene, the acid deriv-
ative acrylonitrile, the monocyclic aromatics benzene, toluene, and
the gas phase portion of styrene, and vinyl chloride were trapped
in methanol at 78C using three micro-impingers connected in
series under conditions adapted from a published method (Byrd
et al., 1990). An aliquot (1 ml) of the combined methanol solution
from the micro-impingers was placed in an autosampler vial to
which an internal standard solution (benzene-d6 and styrene-d8)
and undecane were added. The solution was shaken for approxi-
mately 30 s and the undecane phase analyzed by GC with mass
spectrometric detection (GC–MS). Acetamide and the particulate
phase portions of styrene were extracted from a TPM-loaded glass
ﬁber ﬁlter with acetone. The internal standard styrene-d8 was
added to an aliquot of the condensate suspension and analyzed
by GC–MS.
For the determination of 2-nitropropane, mainstream smoke
was trapped on a silica cartridge. After sampling, the internal stan-
dard 2-methyl-2-nitropropane was added to the cartridge. The car-
tridge was eluted with diethyl ether in pentane and 2-nitropropane
was determined by GC with a thermal energy analyzer.
For the determination of aromatic amines (o-anisidine, o-tolui-
dine, 2-naphthylamine, and 4-aminobiphenyl), a TPM-loaded glass
ﬁber ﬁlter was extracted with hydrochloric acid followed by back-
extraction with n-hexane after alkalization. After addition of the
internal standards (o-anisidine-d7, o-toluidine-d9, 2-naphthyl-
amine-d7, and 4-aminobiphenyl-d9), the sample was derivatized
with perﬂuoro propionic anhydride. The sample was analyzed by
GC with tandemmass spectrometric detection (MS/MS) in the neu-
tral loss scan mode. Quantiﬁcation was performed using a standard
additionmethod, or by the use of multiple internal standards (Stab-
bert et al., 2003b).
For the determination of hydrogen cyanide, undiluted cigarette
mainstream smoke was trapped in two impingers connected in
series, each containing a sodium hydroxide solution. Hydrogen
cyanide was determined by headspace GC with a nitrogen phos-
phorous detector after acidiﬁcation of the samples.
Ammonia was trapped on a glass ﬁber ﬁlter connected in series
to a wash bottle ﬁlled with diluted sulfuric acid. The determination
was performed by reversed-phase chromatography with ﬂuores-
cence detection after derivatization with ﬂuorescamine using
1-butylamine as an internal standard (Mizobuchi et al., 1984).
For the determination of the tobacco-speciﬁc nitrosamines
N-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyr-
idyl)-1-butanone (NNK), a published method (Wagner et al.,
2005) was adapted. TPM was trapped on a glass ﬁber ﬁlter and ex-
tracted with ammonium acetate solution containing the deuter-
ated internal standards (NNN-d4 and NNK-d4). The extract was
ﬁltered and an aliquot analyzed directly by LC-MS/MS.
Phenolic compounds were extracted with trichloromethane
from a TPM-loaded glass ﬁber ﬁlter. An aliquot of the extract and
the added internal standards phenol-d6 and catechol-d6 were
derivatized with N,O-bis(trimethyl-silyl)triﬂuoroacetamide. The
trimethyl-silyl derivatives of the phenols were analyzed by GC–
MS (Nanni et al., 1990).
The polycyclic aromatic hydrocarbons (PAHs) pyrene,
benz[a]anthracene, benzo[b]ﬂuoranthene, benzo[j]ﬂuoranthene,
benzo[k]ﬂuoranthene, dibenz[a,h]anthracene, dibenzo[a,e]pyrene,
dibenzo[a,h]pyrene, dibenzo[a,i]pyrene, benzo[a]pyrene, diben-
zo[a,l]pyrene, indeno (1,2,3-cd)pyrene, and 5-methylchrysenewere
extractedwithpentane:isooctane (9:1) andan internal standardmix
(pyrene-d10, benzo[a]anthracene-d12, benzo[b]ﬂuoranthene-d12,
benzo[a]pyrene-d12, dibenzo[a,h]anthracene-d14, dibenzo[a,i]pyr-
ene-d14, and indeno(1,2,3-cd)pyrene-d12) was added to the extract.
The extract was concentrated under a nitrogen stream and cleaned
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tridge, and then with a C18 cartridge. The eluate was concentrated
and injected into the GC–MS.
Hexamethylenetetramine (HMT) was trapped on a glass ﬁber
ﬁlter, extracted with methanol, and determined by GC with a mass
selective detector. An external calibration method or isoquinoline
as internal standard were used.
For the determination of cadmium, chromium, nickel, and lead,
the smoke samples were completely mineralized by wet ashing
with sulfuric and nitric acid. In the digestion solution, the elements
were determined by graphite furnace atomic absorption spectrom-
etry (AAS).
For the determination of arsenic, dry ashing oxidation of the
smoke sample was performed in the presence of the ashing aid
Mg(NO3)2. The ash from the sample was dissolved in hydrochloric
acid. Total arsenic present in the solution was reduced to the triva-
lent state with potassium iodide and ascorbic acid. After adding so-
dium borohydride, the volatile arsine was determined by AAS
(hydride technique).
2.6. Neutral Red Uptake assay
The NRU in vitro cytotoxicity assay developed by Borenfreund
and coworkers (Borenfreund and Puerner, 1985; Babich and Boren-
freund, 1992) has been widely used and accepted by the chemical
and pharmaceutical industry as a screening method to determine
the cytotoxicity of compounds (National Institute of Health,
2001). This test is known to be responsive to both the TPM and
GVP (Tewes et al., 2003) and it can discriminate between different
cigarette tobacco types (Bombick et al., 1998). The assay is a well-
established, reproducible, and standardized short-term test that
responds to cytotoxic compounds in a dynamic range of ﬁve orders
of magnitude (Borenfreund et al., 1988). In this study, the cytotoxic
activity of both TPM and GVP from the various cigarette types was
determined. Three TPM and GVP batches for each cigarette and
smoking regimen were prepared and tested separately.
Cytotoxicity was determined in the NRU assay according to the
INVITTOX protocol No. 3a (INVITTOX, 1990). Exposure was per-
formed by incubating mouse embryo BALB/c 3T3 cells for 24 h in
culture medium to which suspensions/solutions of TPM or GVP
were added within one hour after preparation. At the end of expo-
sure, this culture medium was replaced by medium containing the
vital dye neutral red. After a three hour incubation period, the neu-
tral red, which was retained in the lysosomes of viable cells only,
was determined photometrically. The EC50 value was determined
and reﬂects that concentration that reduces the number of viable
cells by 50% compared to the corresponding solvent control. In
each test, acrolein was used as concurrent positive control to con-
ﬁrm the test performance.
2.7. Salmonella typhimurium Reverse Mutation assay
The S. typhimurium Reverse Mutation (Ames) assay as described
by Maron and Ames (1983) is a widely used, short-term, bacterial
in vitro genotoxicity test, designed to detect point mutations in-
duced by single chemicals and complex environmental and biolog-
ical mixtures. The test is recommended by Organization for
Economic Co-operation and Development (OECD) and the Interna-
tional Conference on Harmonization (ICH) as part of the standard
testing battery for genotoxicity (Organization for Economic Co-
operation and Development, 1997; International Conference on
Harmonization, 1995). The test uses histidine-requiring strains of
bacteria, S. typhimurium, to detect point mutations which involve
substitution, addition, and deletion of one or more DNA base pairs.
The principle of this test is that it detects mutations that revert
mutations present in the tester strains and restores the functionalcapability of the bacteria to synthesize the essential amino acid
histidine (Ames et al., 1975).
Five strains of S. typhimurium are routinely used to determine
the potential mutagenicity of test substances: strains TA98 and
TA1537 which detect frameshift mutations, strains TA100 and
TA1535 which detect base-pair substitution at guanine-cytosine
base pairs, and strain TA102 which exhibits an adenine–thymine
base pair at the primary reversion site and can detect certain oxi-
dizing mutagens, cross-linking agents, and hydrazines. The plate
incorporation version of the Ames assay was used and applied to
TPM only, because this assay version is not capable of detecting
the mutagenic potential of GVP. The Ames assay can discriminate
the mutagenic activity of TPM from different types of cigarettes
(Roemer et al., 1998) with different ﬁlter ventilation, ﬁlter efﬁ-
ciency, paper porosity (Tewes et al., 1999), and tobacco types as
well as cigarette smoke fractions (DeMarini, 1983).
In order to mimic mammalian metabolism, the TPM-DMSO sus-
pensions were also tested in the presence of a metabolic activation
system. This is a cofactor-supplemented, post-mitochondrial frac-
tion (S9) prepared from the livers of rats treated with the en-
zyme-inducing agent Aroclor 1254 (Cytotest Cell Research,
Rossdorf, Germany; batch No. 220304).
The Ames assay is sensitive to TPM, but this sensitivity depends
on the tester strain and the presence or absence of S9 metabolic
activation. Strains TA102 and TA1535 with and without S9 meta-
bolic activation show no or only a marginal response to TPM.
TA98 and TA1537 without S9 metabolic activation are typically
just above a borderline response; a higher response is obtained
using TA100 without S9 metabolic activation and TA1537 with
S9 metabolic activation (Roemer et al., 2002). The strains that are
most sensitive towards TPM are TA98 and TA100 with S9 meta-
bolic activation.
The Ames test was performed in compliance with OECD guide-
line 471 (Organization for Economic Co-operation and Develop-
ment, 1997), with a deviation from the dose selection (fewer and
lower doses than recommended), taking into account that TPM is
known to be mutagenic. In each test, concurrent positive controls
(strain-, S9-, and test substance-speciﬁc) and negative controls
(solvent), with and without S9 metabolic activation, were evalu-
ated and used to conﬁrm the test performance.3. Statistical analysis
3.1. Smoke chemistry
As descriptive statistics, the number of determinations (N), the
arithmetic mean (M), and the standard error (SE) are presented.
The limits of quantiﬁcation (LOQ) on a per cigarette basis were
determined as the instrument signal-to-noise ratio of 10:1. The
detection limit was one-third of the LOQ. For samples including
at least one measured value below the LOQ, only the median or
the LOQ is given, depending on whether the median is above or be-
low the LOQ.3.2. Neutral Red Uptake assay
As descriptive statistics, the arithmetic mean (M) and the stan-
dard error (SE) are given.
Three TPM and GVP batches of each cigarette type and smoking
regimen were tested separately, one batch per assay. Each TPM and
GVP batch was tested at eight different doses resulting in sigmoid
dose–response curves. The EC50, which represents the test
substance concentration that reduces the number of viable cells
by 50% compared to the untreated control culture, was determined
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moid function:
Abs ¼ Max
1þ ConcEC50
 Slope
where:
Abs: absorbance relative to control
Conc: concentration of test substance
Max: maximum absorbance value
Slope: slope at inﬂection point
EC50: concentration causing a 50% effect
As measure of cytotoxicity, the reciprocal EC50 values were
calculated.
3.3. Salmonella typhimurium Reverse Mutation assay
As descriptive statistics, the arithmetic mean (M) and the stan-
dard error (SE) are presented.
The mutagenicity results are based on the number of colonies
that revert to histidine prototrophy and are given for each strain
in the presence and absence of S9 metabolic activation.
Two TPM batches of each cigarette type and smoking regimen
were tested separately, one batch per assay. Each TPM batch was
tested at three different doses. For the sensitive strains, these were
approximately within the linear part of the dose–response curve.
For each TPM batch (per strain and metabolic activation), Pois-
son-weighted linear regression analysis excluding the solvent con-
trol was performed on the dose–response curve. The regression
slopes were deﬁned as the measure of mutagenicity (revertants
per mg TPM).4. Results
As the settings of smoking machines reﬂected human pufﬁng
behavior conditions, derived from the 10th and 90th percentile
of the nicotine uptake distribution measured in a clinical study,
all results are reported on a per cigarette basis.
4.1. Smoke chemistry
Mainstream smoke from cigarettes used in this study was ana-
lyzed for TPM, tar, water, nicotine, carbon monoxide and up to 44
additional HPHC.
4.1.1. ISO smoking conditions
In mainstream smoke from the EHCSS series-K cigarettes, the
yields of 11 HPHC were below the LOQ for all cigarettes (7 PAHs,
crotonaldehyde, chromium, nickel, and arsenic). In addition, o-
anisidine, 4-aminobiphenyl, vinyl chloride, NNK, HMT, cadmium,
and lead were below LOQ for one or two of the cigarettes (Table 2).
In mainstream smoke from the conventional lit-end cigarettes,
the yields of 8 HPHC were below LOQ for all cigarettes (6 PAHs,
chromium, and nickel). In addition, crotonaldehyde, 2-nitropro-
pane, vinyl chloride, benzo[j]ﬂuoranthene, benzo[k]ﬂuoranthene,
and indeno(1,2,3-c,d)pyrene were below LOQ for two or three of
the cigarettes (Table 3).
For all HPHC that could be quantiﬁed in mainstream smoke
from both types of cigarettes, the EHCSS series-K cigarettes exhib-
ited lower yields than the 6 mg ISO tar target lit-end cigarettes
(M6UK and M6J) except for water (all EHCSS series-K cigarettes)
and formaldehyde (EHCSS-K6M only). Compared to the 1 mg ISO
tar target lit-end cigarettes (PM1 and Lark1) at least two-thirds
of those HPHC were lower for the EHCSS series-K cigarettes.4.1.2. HPB conditions
For mainstream smoke obtained from EHCSS-K6, EHCSS–K3 and
CC, the yield of almost all HPHC increased with increasing pufﬁng
intensity (Table 4–9).
4.1.3. EHCSS-K6
Considering the results obtained for EHCSS-K6 under the vari-
ous smoking conditions, the maximum increase in HPHC yields
ranged up to a factor of 6 for half of the HPHC, whereas for the
remaining half, it ranged above a factor of 6 with high factors for
hydrogen cyanide (12), benzene and benzo[j]ﬂuoranthene
(11), phenol (30), benz[a]anthracene (14), and cadmium (at
least 17). The yields of crotonaldehyde, six PAHs, chromium, lead,
and arsenic were below LOQ under all HPB conditions (Table 4).
4.1.4. EHCSS-K3
Considering the results obtained for EHCSS-K3 under the vari-
ous smoking conditions, the maximum increase in HPHC yields
ranged up to a factor of 7 for approximately two-thirds of the
HPHC, whereas for the remaining one-third, the maximum in-
crease ranged above a factor of 7 with high factors for hydrogen
cyanide (17), benzene and styrene (11), the PAHs (11 to
23), and cadmium (12). The yields of ﬁve PAHs, chromium,
nickel, and arsenic were below LOQ regardless of the HPB condi-
tions (Table 5).
4.1.5. Conventional lit-end cigarettes
When considering the results obtained for M6UK under the vari-
ous smoking conditions, the maximum increase for approximately
95% of the HPHC was up to a factor of 5. Exceptions were water
and styrene with factors up to 7 (Table 6). For M6J, themaximum in-
crease for approximately 90% of the HPHC was up to a factor of 15.
Exceptions were acetaldehyde, acrolein, propionaldehyde, hydrogen
cyanide, and styrene exhibiting factors up to 35 (Table 7). For PM1,
the maximum increase for approximately 90% of the HPHC was up
to a factor of 10. Exceptions were acetamide, hydrogen cyanide, sty-
rene, phenol, and lead with factors up to 26 (Table 8). For Lark1, the
maximum increase for approximately 80% of the HPHC was up to a
factor of 13. Exceptions were acrolein, acetamide, acrylonitrile,
hydrogen cyanide, phenol, cadmium, and lead exhibiting factors up
to 50 (Table 9), suggesting some ﬁnite carbon ﬁltering capacity
(e.g., Laugesen and Fowles, 2006). For the CC, the yields of
dibenz[a,h]anthracene, dibenzo[a,h]pyrene, dibenzo[a,i]pyrene, di-
benzo[a,l]pyrene, 5-methylchrysene, chromium, and nickel obtained
under almost all HPB conditions were below LOQ. Only under the
least intense HPB condition applied, dibenzo[a,e]pyrene was below
LOQ for M6J, PM1, and Lark1.
4.2. Neutral Red Uptake assay
4.2.1. ISO smoking conditions
TPM and GVP from the EHCSS-K6, EHCSS-K3, and CC were ap-
plied to BALB/c 3T3 cells in a range where concentration-depen-
dent responses were induced. Cytotoxicity of TPM and GVP from
both EHCSS-K6 and EHCSS-K3 was lower than that of M6UK and
M6J. Cytotoxicity of TPM from the ECHSS-K6 was comparable to
that of PM1, but higher than that of Lark1, while that of the
EHCSS-K3 was lower than that of both PM1 and Lark1. Cytotoxicity
of GVP from the ECHSS-K6 was higher than that of both PM1 and
Lark1, while that of the EHCSS-K3 was lower than that of PM1,
but higher than that of Lark1 (Table 10).
4.2.2. HPB conditions
Cytotoxicity showed a broad response range as a function of
smoking intensity for all cigarettes smoked under HPB conditions.
An increase in pufﬁng intensity was generally associated with an
Table 2
Yields from the EHCSS-K6, EHCSS-K6M, and EHCSS-K3 obtained under ISO smoking conditions.
Parameter Unit EHCSS-K6 EHCSS-K6M EHCSS-K3
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.00 ± 0.00 8 8.00 ± 0.00 4 8.00 ± 0.00 4
TPM mg/cig. 5.94 ± 0.14 8 5.09 ± 0.05 4 3.59 ± 0.02 4
Tar ‘‘ 3.02 ± 0.12 8 3.22 ± 0.05 4 2.29 ± 0.03 4
Nicotine ‘‘ 0.284 ± 0.006 8 0.223 ± 0.002 4 0.204 ± 0.008 4
Water ‘‘ 2.63 ± 0.05 8 1.65 ± 0.05 4 1.09 ± 0.01 4
Carbon monoxide ‘‘ 0.455 ± 0.005 4 0.501 ± 0.011 4 0.413 ± 0.002 4
Aliphatic dienes
1,3-Butadiene lg/cig. 1.71 ± 0.07 4 1.82 ± 0.10 4 0.980 ± 0.068 4
Isoprene ‘‘ 30.8 ± 0.8 4 30.5 ± 1.0 4 26.1 ± 0.7 4
Aldehydes
Formaldehyde lg/cig. 11.3 ± 0.3 5 13.8 ± 1.0 5 10.1 ± 0.4 5
Acetaldehyde ‘‘ 141 ± 2 5 132 ± 6 5 148 ± 2 5
Acrolein ‘‘ 22.7 ± 1.1 5 23.8 ± 1.2 5 16.6 ± 0.7 5
Propionaldehyde ‘‘ 5.13 ± 0.16 5 5.74 ± 0.36 5 5.18 ± 0.16 5
Crotonaldehyde ‘‘ <5.50 5 n.d. <2.60 5
Acid derivatives
Acetamide lg/cig. 1.09 ± 0.05 4 0.900 ± 0.025 4 0.385 ± 0.012 4
Acrylonitrile ‘‘ 0.528 ± 0.011 4 0.569 ± 0.010 4 0.316 ± 0.055 4
Nitro compounds
2-Nitropropane ng/cig. 5.87 ± 0.20 4 8.98 ± 0.37 4 4.19 ± 0.36 4
Aromatic amines
o-Toluidine ng/cig. 0.885 ± 0.025 4 0.632 ± 0.031 4 0.519 ± 0.043 4
o-Anisidine ‘‘ 0.141 ± 0.002 4 <0.200 4 <0.137 4
2-Naphthylamine ‘‘ 0.108 ± 0.002 4 0.082 ± 0.002 4 0.099 ± 0.006 4
4-Aminobiphenyl ‘‘ 0.050 ± 0.001 4 <0.113 4 0.048 4
Halogen compounds
Vinyl chloride ng/cig. 6.31 4 <12.4 4 8.04 ± 0.23 4
Inorganic compounds
Nitrogen oxides lg/cig. 30.4 ± 0.2 4 17.5 ± 0.4 4 35.3 ± 0.5 4
Hydrogen cyanide ‘‘ 2.99 ± 0.16 4 2.30 ± 0.11 4 4.03 ± 0.06 4
Ammonia ‘‘ 8.89 ± 0.23 4 n.d. 6.03 ± 0.10 4
Monocyclic aromatics
Benzene lg/cig. 0.305 ± 0.006 4 0.319 ± 0.007 4 0.209 ± 0.009 4
Toluene ‘‘ 1.12 ± 0.03 4 1.07 ± 0.02 4 0.749 ± 0.025 4
Styrene ‘‘ 0.145 ± 0.005 4 0.134 ± 0.005 4 0.075 ± 0.003 4
N-Nitrosamines
NNN lg/cig. 19.5 ± 0.4 4 16.5 ± 0.3 4 16.0 ± 0.3 4
NNK ‘‘ 5.39 ± 0.13 4 <12.0 4 4.27 ± 0.05 4
Phenols
Phenol lg/cig. 0.137 ± 0.012 4 0.059 ± 0.002 4 0.022 ± 0.002 4
Catechol ‘‘ 5.38 ± 0.17 4 4.76 ± 0.09 4 3.18 ± 0.07 4
PAHs
Pyrene ng/cig. 0.321 ± 0.022 4 0.519 ± 0.010 4 0.136 ± 0.018 4
Benz[a]anthracene ‘‘ 0.064 ± 0.003 4 0.064 ± 0.001 4 0.077 ± 0.003 4
Benzo[b]ﬂuoranthene ‘‘ 0.046 ± 0.001 4 0.039 ± 0.002 4 0.046 ± 0.003 4
Benzo[j]ﬂuoranthene ‘‘ 0.024 ± 0.001 4 0.023 4 0.028 ± 0.002 4
Benzo[k]ﬂuoranthene ‘‘ <0.021 4 <0.021 4 <0.021 4
Benzo[a]pyrene ‘‘ 0.051 ± 0.003 4 0.045 ± 0.002 4 0.059 ± 0.006 4
Indeno(1,2,3-cd)pyrene ‘‘ 0.035 ± 0.002 4 0.026 ± 0.001 4 0.032 ± 0.003 4
Dibenz[a,h]anthracene ‘‘ <0.034 4 <0.034 4 <0.034 4
Dibenzo[a,e]pyrene ‘‘ <0.033 4 <0.033 4 <0.033 4
Dibenzo[a,h]pyrene ‘‘ <0.067 4 <0.067 4 <0.067 4
Dibenzo[a,i]pyrene ‘‘ <0.050 4 <0.050 4 <0.050 4
Dibenzo[a,l]pyrene ‘‘ <0.031 4 <0.031 4 <0.031 4
5-Methylchrysene <0.025 4 <0.025 4 <0.025 4
Amines ‘‘
HMT lg/cig. 0.088 ± 0.012 4 n.d. <0.054 4
Metals
Cadmium ng/cig. <0.250 3 <0.222 3 0.242 ± 0.022 3
Chromium ‘‘ <0.625 3 <0.556 3 <0.418 3
Nickel ‘‘ <1.25 3 <1.11 3 <0.836 3
Lead ‘‘ <1.25 3 <1.11 3 6.23 ± 2.37 3
Arsenic ‘‘ <0.625 3 <0.556 3 <0.417 3
Remarks: SE, standard error; N, number of determinations; n.d., not determined.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 3
Yields from the M6UK, M6J, PM1, and Lark1 obtained under ISO smoking conditions.
Parameter Unit M6UK M6J PM1 Lark1
(mean ± SE) N (mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.38 ± 0.05 4 7.80 ± 0.00 4 7.93 ± 0.06 4 8.85 ± 0.06 4
TPM mg/cig. 8.07 ± 0.15 4 8.08 ± 0.10 4 1.77 ± 0.05 4 1.37 ± 0.03 4
Tar ‘‘ 6.65 ± 0.12 4 6.64 ± 0.07 4 1.46 ± 0.03 4 1.12 ± 0.02 4
Nicotine ‘‘ 0.544 ± 0.010 4 0.482 ± 0.003 4 0.151 ± 0.004 4 0.096 ± 0.002 4
Water ‘‘ 0.870 ± 0.052 4 0.951 ± 0.045 4 0.167 ± 0.017 4 0.153 ± 0.011 4
Carbon monoxide ‘‘ 8.31 ± 0.06 4 8.74 ± 0.16 4 2.41 ± 0.06 4 1.46 ± 0.04 4
Aliphatic dienes
1,3-Butadiene lg/cig. 28.1 ± 0.5 4 19.1 ± 0.3 4 9.35 ± 0.34 4 3.51 ± 0.33 4
Isoprene ‘‘ 290 ± 3 4 169 ± 8 4 110 ± 3 4 43.1 ± 4.0 4
Aldehydes
Formaldehyde lg/cig. 17.5 ± 0.7 5 13.8 ± 0.4 5 1.76 ± 0.04 5 0.869 ± 0.045 5
Acetaldehyde ‘‘ 432 ± 7 5 333 ± 7 5 106 ± 0 5 42.0 ± 2.6 5
Acrolein ‘‘ 50.0 ± 1.4 5 28.0 ± 0.6 5 9.96 ± 0.22 5 2.24 ± 0.18 5
Propionaldehyde ‘‘ 38.2 ± 0.6 5 26.5 ± 0.6 5 9.79 ± 0.06 5 3.19 ± 0.21 5
Crotonaldehyde ‘‘ 6.49 ± 0.19 5 <5.50 5 <5.50 5 <5.50 5
Acid derivatives
Acetamide lg/cig. 2.99 ± 0.12 4 3.27 ± 0.05 4 0.453 ± 0.013 4 0.305 ± 0.015 4
Acrylonitrile ‘‘ 8.69 ± 0.21 4 5.10 ± 0.14 4 2.89 ± 0.06 4 0.770 ± 0.061 4
Nitro compounds
2-Nitropropane ng/cig. 6.28 ± 0.46 4 <3.80 4 <3.80 4 <3.80 4
Aromatic amines
o-Toluidine ng/cig. 37.9 ± 1.2 4 40.1 ± 1.2 4 7.74 ± 0.20 4 5.33 ± 0.25 4
o-Anisidine ‘‘ 1.55 ± 0.11 4 1.59 ± 0.09 4 0.369 ± 0.130 4 0.279 ± 0.01 4
2-Naphthylamine ‘‘ 4.36 ± 0.11 4 4.54 ± 0.09 4 1.34 ± 0.04 4 1.20 ± 0.05 4
4-Aminobiphenyl ‘‘ 0.837 ± 0.016 4 0.840 ± 0.005 4 0.291 ± 0.013 4 0.228 ± 0.01 4
Halogen compounds
Vinyl chloride ng/cig. 18.0 ± 0.8 4 15.2 ± 0.4 4 <12.4 4 <12.4 4
Inorganic compounds
Nitrogen oxides lg/cig. 110 ± 1 4 128 ± 2 4 69.1 ± 1.4 4 59.5 ± 1.8 4
Hydrogen cyanide ‘‘ 44.2 ± 1.4 4 29.3 ± 1.0 4 9.82 ± 0.30 4 1.47 ± 0.11 4
Ammonia ‘‘ n.d. n.d. n.d. n.d.
Monocyclic aromatics
Benzene lg/cig. 30.5 ± 0.2 4 16.9 ± 0.4 4 11.4 ± 0.1 4 3.00 ± 0.28 4
Toluene ‘‘ 48.3 ± 0.5 4 23.0 ± 0.7 4 15.2 ± 0.4 4 3.81 ± 0.26 4
Styrene ‘‘ 2.45 ± 0.02 4 0.873 ± 0.052 4 0.753 ± 0.040 4 0.140 ± 0.011 4
N-Nitrosamines
NNN lg/cig. 62.2 ± 2.4 4 92.7 ± 3.5 4 43.9 ± 1.4 4 23.9 ± 0.2 4
NNK ‘‘ 43.0 ± 1.9 4 61.9 ± 2.2 4 18.2 ± 0.5 4 13.1 ± 0.2 4
Phenols
Phenol lg/cig. 7.75 ± 0.33 4 6.33 ± 0.07 4 0.648 ± 0.028 4 0.315 ± 0.010 4
Catechol ‘‘ 41.3 ± 1.4 4 38.2 ± 0.2 4 9.52 ± 0.23 4 6.52 ± 0.04 4
PAHs
Pyrene ng/cig. 28.4 ± 0.5 4 28.5 ± 0.2 4 5.62 ± 0.05 4 5.19 ± 0.15 3
Benz[a]anthracene ‘‘ 7.44 ± 0.20 4 7.84 ± 0.09 4 1.54 ± 0.02 4 1.63 ± 0.04 4
Benzo[b]ﬂuoranthene ‘‘ 3.99 ± 0.12 4 4.15 ± 0.15 4 0.785 ± 0.006 4 0.740 ± 0.025 4
Benzo[j]ﬂuoranthene ‘‘ 2.18 ± 0.05 4 2.18 ± 0.09 4 <0.520 4 <0.520 4
Benzo[k]ﬂuoranthene ‘‘ 1.46 ± 0.05 4 1.45 ± 0.08 4 <0.470 4 <0.470 4
Benzo[a]pyrene ‘‘ 5.05 ± 0.16 4 5.37 ± 0.16 4 0.968 ± 0.006 4 1.01 ± 0.03 4
Indeno(1,2,3-cd)pyrene ‘‘ 2.16 ± 0.05 4 2.39 ± 0.12 4 0.425 ± 0.004 4 0.422 ± 0.014 4
Dibenz[a,h]anthracene ‘‘ <0.970 4 <0.970 4 <0.970 4 <0.970 4
Dibenzo[a,e]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,h]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,i]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,l]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4 <0.200 4
5-Methylchrysene <0.400 4 <0.400 4 <0.400 4 <0.400 4
Amines ‘‘
HMT lg/cig. n.d. n.d. n.d. n.d.
Metals
Cadmium ng/cig. 10.1 ± 0.6 3 5.06 ± 0.31 3 1.60 ± 0.14 3 0.51 ± 0.01 3
Chromium ‘‘ <0.833 3 <0.833 3 <0.208 3 <0.156 3
Nickel ‘‘ <1.67 3 <1.67 3 <0.417 3 <0.313 3
Lead ‘‘ 7.56 ± 0.34 3 10.1 ± 0.4 3 0.819 ± 0.028 3 0.406 ± 0.048 3
Arsenic ‘‘ 1.30 ± 0.04 3 1.49 ± 0.22 3 0.247 ± 0.010 3 0.284 ± 0.007 3
Remarks: SE, standard error; N, number of determinations; n.d., not determined.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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and GVP (Table 11).
4.2.3. EHCSS-K6
Cytotoxicity of TPM and GVP from the EHCSS-K6 generally in-
creased with increasing pufﬁng intensity (Fig. 1). Considering the
complete range of applied HPB conditions, a 6.2-fold increase in
cytotoxicity of TPM and a 2.5-fold increase in cytotoxicity of GVP
was observed. Due to technical reasons during sample generation,
cytotoxicity of the TPM and GVP obtained under HPB condition
MED2L could not be determined.
4.2.4. EHCSS-K3
Also for the EHCSS-K3, cytotoxicity of TPM and GVP increased
with increasing pufﬁng intensity exhibiting a 4.9-fold increase in
cytotoxicity of TPM and a 3.6-fold increase in cytotoxicity of GVP.
4.2.5. Conventional lit-end cigarettes
Cytotoxicity of TPM and GVP from the CC also showed a clear
increase with increasing pufﬁng intensity.
4.3. Salmonella typhimurium Reverse Mutation assay
The number of revertants seen in strains TA102 and TA1535
with and without S9 metabolic activation was similar or only
slightly higher after TPM exposure than in the solvent control.
Therefore, the results for these two strains are not discussed
further.
4.3.1. ISO smoking conditions
TPM from the EHCSS series-K and the CC was applied to the S.
typhimurium strains in a range where concentration dependent re-
sponses were induced. In the most sensitive assay parameters,
strains TA98, TA100, and TA1537 with S9 metabolic activation,
the bacterial mutagenicity of TPM from the EHCSS series-K ciga-
rettes was always lower than that of TPM from the CC (Table 12).
4.3.2. HPB conditions
The bacterial mutagenicity showed a broad response range as a
function of smoking intensity for all cigarettes smoked under HPB
conditions. An increase in pufﬁng intensity was generally associ-
ated with an increase in TPM and nicotine yield as well as in bac-
terial mutagenicity of TPM (Table 13).
4.3.3. EHCSS-K6
Bacterial mutagenicity of TPM from the EHCSS-K6 generally in-
creased with increasing pufﬁng intensity (Fig. 2). Considering the
complete range of HPB conditions applied, 26-fold (TA98), 18-fold
(TA100), and 36-fold (TA1537) increases in bacterial mutagenicity
of TPM were observed with S9 metabolic activation. Similar trends
were observed for the bacterial mutagenicity of TPM without S9
metabolic activation.
4.3.4. EHCSS-K3
Also for the EHCSS-K3, bacterial mutagenicity of TPM increased
with increasing pufﬁng intensity exhibiting 12-fold (TA98), 13-fold
(TA100), and 15-fold (TA1537) increases.
4.3.5. Conventional lit-end cigarettes
Bacterial mutagenicity of TPM from the CC in the presence of S9
metabolic activation also showed a clear increase with increasing
pufﬁng intensities and similar trends in the absence of S9 meta-
bolic activation.4.4. HPHC/toxicity parameter-to-nicotine regressions
HPHC/toxicity parameter-to-nicotine regressions were per-
formed visualizing the correlations between nicotine and HPHC
yields or toxicological effects, respectively, as a function of pufﬁng
intensity. TPM, tar, and 32 of the 49 HPHC measured as well as 5
toxicity parameters were used for regression analyses. The inter-
cept, slope, and coefﬁcient of determination (r2) of these regres-
sions are reported by Urban et al. (2012). Criteria for selecting
HPHC and toxicological effects for regression analyses were the
availability of mean valuesP LOQ for at least 4 smoking protocols
and the calculability of the regressions with nicotine for the
EHCSS-K6, the M6UK, and the PM1.
4.5. Smoke chemistry
Due to insufﬁcient availability of data points, regression analy-
sis was not performed for crotonaldehyde, vinyl chloride,
benzo[k]ﬂuoranthene, dibenzo[a,h]anthracene, dibenzo[a,e]pyr-
ene, dibenzo[a,h]pyrene, dibenzo[a,i]pyrene, dibenzo[a,l]pyrene,
5-methylchrysene, and HMT.
For the EHCSS series-K cigarettes, aldehydes, N-nitrosamines,
inorganic compounds, TPM, tar, nicotine, water, isoprene, acetam-
ide, 2-nitropropane, o-anisidine, 4-aminobiphenyl, vinyl chloride,
and catechol showed a linear correlation versus nicotine yields
(for examples see Figs. 3 and 7). For the monocyclic aromatics,
PAHs, carbon monoxide, 1,3-butadiene, acrylonitrile, o-toluidine,
2-naphthylamine, pyrene, and phenol, the regression analysis re-
sulted in an exponential relationship (for examples see Figs. 4–6).
The results for the CC showed a strong linear correlation for al-
most all HPHC versus nicotine yield (for examples see Figs. 3–7),
although the slopes were expected to differ between cellulose ace-
tate and carbon ﬁlter tipped cigarettes.
4.6. Neutral Red Uptake assay
Cytotoxicity values for both TPM and GVP from the EHCSS-K6
and EHCSS-K3 showed an exponential relationship to the nicotine
yields, while strong linear correlations were found for the CC (Figs.
8 and 9).
4.7. Salmonella typhimurium Reverse Mutation assay
Bacterial mutagenicity values for TPM from the EHCSS-K6 and
EHCSS-K3 in strains TA98, TA100, and TA1537 with S9 metabolic
activation showed an exponential relationship to the nicotine
yields, while linear correlations were found for the CC (Fig. 10).5. Discussion
The objective of this study is to assess the potential for reduced
exposure to HPHC from EHCSS series-K compared to CC as deter-
mined by chemical analysis as well as by in vitro cytotoxicity and
bacterial mutagenicity testing under a variety of smoking regimens
reﬂecting the variability in human smoking behavior.
Comparisons of different cigarette designs on a ‘per cigarette
basis’ are potentially misleading, because the regulatory mandated
smoking regimen (e.g., European Communities, 2001; Health Can-
ada, 1999) under which the ‘per cigarette data’ are obtained do not
reﬂect human smoking behavior and thus smokers’ exposure
(Schorp et al. 2012). Consequently, the U.S. Federal Trade Commis-
sion (FTC) has ofﬁcially rescinded its guidance for reporting smok-
ing machine tar and nicotine yields (Federal Trade Commission,
2008). However, examining HPHC-to-nicotine relationships as
determined under HPB conditions, are a logical consequence of
Table 4
Yields from the EHCSS-K6 obtained under HPB conditions.
Parameter Unit EHCSS-K6 LOW4 EHCSS-K6 MED1 EHCSS-K6 MED2L
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.00 ± 0.00 8 8.00 ± 0.00 8 8.00 ± 0.00 8
TPM mg/cig. 9.81 ± 0.53 8 8.99 ± 0.15 8 6.12 ± 0.06 8
Tar ‘‘ 5.45 ± 0.18 8 4.26 ± 0.14 8 3.35 ± 0.04 8
Nicotine ‘‘ 0.171 ± 0.002 8 0.356 ± 0.009 8 0.119 ± 0.001 8
Water ‘‘ 4.19 ± 0.42 8 4.37 ± 0.08 8 2.66 ± 0.04 8
Carbon monoxide ‘‘ 0.507 ± 0.008 4 0.420 ± 0.006 4 0.373 ± 0.013 4
Aliphatic dienes
1,3-Butadiene lg/cig. 2.92 ± 0.17 4 1.69 ± 0.04 4 1.65 ± 0.05 4
Isoprene ‘‘ 55.0 ± 3.7 4 30.0 ± 0.4 4 31.8 ± 0.9 4
Aldehydes
Formaldehyde lg/cig. 14.0 ± 0.3 5 18.8 ± 1.6 5 18.1 ± 1.4 5
Acetaldehyde ‘‘ 184 ± 5 5 174 ± 11 5 127 ± 5 5
Acrolein ‘‘ 26.4 ± 0.9 5 25.3 ± 1.1 5 18.7 ± 1.2 5
Propionaldehyde ‘‘ 8.48 ± 0.22 5 7.33 ± 0.50 5 4.60 ± 0.22 5
Crotonaldehyde ‘‘ <5.50 5 <5.50 5 <5.50 5
Acid derivatives
Acetamide lg/cig. 0.530 ± 0.019 4 1.67 ± 0.04 4 0.603 ± 0.014 4
Acrylonitrile ‘‘ 0.873 ± 0.042 4 0.618 ± 0.005 4 0.583 ± 0.012 4
Nitro compounds
2-Nitropropane ng/cig. 9.66 ± 0.22 4 5.53 ± 0.08 4 n.d.
Aromatic amines
o-Toluidine ng/cig. 0.415 ± 0.008 5 1.16 ± 0.06 4 0.317 ± 0.008 4
o-Anisidine ‘‘ 0.060 ± 0.002 5 0.180 ± 0.009 4 0.043 ± 0.002 4
2-Naphthylamine ‘‘ <0.060 5 0.122 ± 0.006 4 <0.060 4
4-Aminobiphenyl ‘‘ 0.026 ± 0.001 5 0.062 ± 0.002 4 0.018 ± 0.001 4
Halogen compounds
Vinyl chloride ng/cig. 9.34 ± 0.36 4 6.47 4 6.31 4
Inorganic compounds
Nitrogen oxides lg/cig. 39.1 ± 1.0 4 32.2 ± 0.3 4 27.6 ± 0.4 4
Hydrogen cyanide ‘‘ 3.47 ± 0.10 4 4.50 ± 0.23 4 8.44 ± 0.56 4
Ammonia ‘‘ 12.3 ± 0.4 4 16.6 ± 0.5 4 n.d.
Monocyclic aromatics
Benzene lg/cig. 0.523 ± 0.023 4 0.363 ± 0.009 4 0.372 ± 0.009 4
Toluene ‘‘ 1.87 ± 0.10 4 1.29 ± 0.03 4 1.30 ± 0.01 4
Styrene ‘‘ 0.250 ± 0.016 4 0.200 ± 0.007 4 0.198 ± 0.003 4
N-Nitrosamines
NNN lg/cig. 10.1 ± 0.7 4 27.4 ± 0.5 4 7.20 ± 0.12 4
NNK ‘‘ 2.76 ± 0.19 4 7.02 ± 0.13 4 1.81 ± 0.01 4
Phenols
Phenol lg/cig. 0.116 ± 0.015 4 0.216 ± 0.014 4 0.095 ± 0.002 4
Catechol ‘‘ 2.44 ± 0.02 4 6.30 ± 0.16 4 2.09 ± 0.04 4
PAHs
Pyrene ng/cig. <0.089 4 0.373 ± 0.056 4 0.096 4
Benz[a]anthracene ‘‘ <0.024 4 0.045 ± 0.005 4 <0.024 4
Benzo[b]ﬂuoranthene ‘‘ <0.022 4 0.039 ± 0.003 4 <0.022 4
Benzo[j]ﬂuoranthene ‘‘ <0.021 4 <0.021 4 <0.021 4
Benzo[k]ﬂuoranthene ‘‘ <0.021 4 <0.021 4 <0.021 4
Benzo[a]pyrene ‘‘ 0.022 3 0.035 ± 0.005 4 <0.016 4
Indeno(1,2,3-cd)pyrene ‘‘ <0.022 2 0.028 ± 0.002 4 <0.013 4
Dibenz[a,h]anthracene ‘‘ <0.034 4 <0.034 4 <0.034 4
Dibenzo[a,e]pyrene ‘‘ <0.033 4 <0.033 4 <0.033 4
Dibenzo[a,h]pyrene ‘‘ <0.067 4 <0.067 4 <0.067 4
Dibenzo[a,i]pyrene ‘‘ <0.050 4 <0.050 4 <0.050 4
Dibenzo[a,l]pyrene ‘‘ <0.031 4 <0.031 4 <0.031 4
5-Methylchrysene <0.025 4 <0.025 4 <0.025 4
Amines ‘‘
HMT lg/cig. <0.076 4 0.188 ± 0.013 4 0.215 ± 0.012 4
Metals
Cadmium ng/cig. <0.308 3 <0.400 3 0.448 ± 0.062 3
Chromium ‘‘ <0.769 3 <1.00 3 <0.714 3
Nickel ‘‘ <1.54 3 <2.00 3 2.38 ± 0.61 3
Lead ‘‘ <1.54 3 <2.00 3 <1.43 3
Arsenic ‘‘ <0.769 3 <1.00 3 <0.714 3
(continued on next page)
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Table 4 (continued)
Parameter Unit EHCSS-K6 MED2U EHCSS-K6 MED4 EHCSS-K6 HIGH1
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.00 ± 0.00 8 8.00 ± 0.00 8 8.00 ± 0.00 8
TPM mg/cig. 17.5 ± 0.3 8 13.3 ± 0.4 8 13.3 ± 0.1 8
Tar ‘‘ 9.40 ± 0.33 8 6.83 ± 0.24 8 6.72 ± 0.26 8
Nicotine ‘‘ 0.608 ± 0.010 8 0.437 ± 0.009 8 0.630 ± 0.020 8
Water ‘‘ 7.49 ± 0.42 8 6.05 ± 0.28 8 5.95 ± 0.29 8
Carbon monoxide ‘‘ 0.820 ± 0.028 4 0.562 ± 0.025 5 0.873 ± 0.133 4
Aliphatic dienes
1,3-Butadiene lg/cig. 4.17 ± 0.27 4 2.48 ± 0.09 4 2.53 ± 0.20 4
Isoprene ‘‘ 64.1 ± 3.2 4 42.7 ± 1.0 4 39.3 ± 1.1 4
Aldehydes
Formaldehyde lg/cig. 31.3 ± 0.5 7 32.6 ± 0.9 7 35.4 ± 0.9 7
Acetaldehyde ‘‘ 248 ± 6 7 210 ± 4 7 213 ± 9 7
Acrolein ‘‘ 42.5 ± 0.9 7 35.9 ± 1.0 7 35.3 ± 1.5 7
Propionaldehyde ‘‘ 11.0 ± 0.4 7 9.75 ± 0.34 7 9.60 ± 0.42 7
Crotonaldehyde ‘‘ <7.40 7 <7.40 7 <7.40 7
Acid derivatives
Acetamide lg/cig. 3.11 ± 0.10 4 1.94 ± 0.06 4 3.14 ± 0.13 4
Acrylonitrile ‘‘ 1.58 ± 0.11 4 0.945 ± 0.037 4 1.06 ± 0.08 4
Nitro compounds
2-Nitropropane ng/cig. 8.95 ± 0.18 4 7.22 ± 0.17 4 n.d.
Aromatic amines
o-Toluidine ng/cig. 3.17 ± 0.13 7 1.47 ± 0.08 5 2.58 ± 0.22 5
o-Anisidine ‘‘ 0.367 ± 0.012 7 0.175 ± 0.008 5 0.314 ± 0.016 5
2-Naphthylamine ‘‘ 0.338 ± 0.026 7 0.124 ± 0.006 5 0.271 ± 0.037 5
4-Aminobiphenyl ‘‘ 0.152 ± 0.008 7 0.066 ± 0.002 5 0.121 ± 0.011 5
Halogen compounds
Vinyl chloride ng/cig. 11.5 ± 0.3 4 10.5 ± 1.1 4 8.82 ± 0.91 4
Inorganic compounds
Nitrogen oxides lg/cig. 57.2 ± 0.5 4 44.4 ± 1.4 5 47.1 ± 2.3 4
Hydrogen cyanide ‘‘ 10.8 ± 0.7 4 7.29 ± 0.42 4 9.91 ± 1.37 4
Ammonia ‘‘ 21.4 ± 0.7 4 22.4 ± 0.8 4 23.6 ± 0.8 4
Monocyclic aromatics
Benzene lg/cig. 0.980 ± 0.058 4 0.518 ± 0.013 4 0.660 ± 0.048 4
Toluene ‘‘ 3.02 ± 0.18 4 1.90 ± 0.05 4 1.99 ± 0.10 4
Styrene ‘‘ 0.450 ± 0.032 4 0.285 ± 0.010 4 0.325 ± 0.020 4
N-Nitrosamines
NNN lg/cig. 49.6 ± 0.2 4 33.2 ± 0.6 4 49.6 ± 0.9 4
NNK ‘‘ 14.2 ± 0.3 4 9.18 ± 0.29 4 13.5 ± 0.2 4
Phenols
Phenol lg/cig. 0.987 ± 0.028 4 0.545 ± 0.027 4 1.01 ± 0.14 4
Catechol ‘‘ 14.5 ± 0.2 4 7.99 ± 0.18 4 12.5 ± 0.6 4
PAHs
Pyrene ng/cig. 1.35 ± 0.35 4 0.418 ± 0.073 4 0.713 ± 0.067 4
Benz[a]anthracene ‘‘ 0.241 ± 0.017 4 0.072 ± 0.004 4 0.152 ± 0.014 4
Benzo[b]ﬂuoranthene ‘‘ 0.144 ± 0.009 4 0.057 ± 0.003 4 0.094 ± 0.006 4
Benzo[j]ﬂuoranthene ‘‘ 0.082 ± 0.006 4 0.031 ± 0.002 4 0.053 ± 0.003 4
Benzo[k]ﬂuoranthene ‘‘ 0.057 ± 0.004 4 <0.021 4 0.035 ± 0.002 4
Benzo[a]pyrene ‘‘ 0.158 ± 0.012 4 0.051 ± 0.005 4 0.090 ± 0.006 4
Indeno(1,2,3-cd)pyrene ‘‘ 0.097 ± 0.006 4 0.043 ± 0.002 4 0.060 ± 0.003 4
Dibenz[a,h]anthracene ‘‘ <0.034 4 <0.034 4 <0.034 4
Dibenzo[a,e]pyrene ‘‘ <0.033 4 <0.033 4 <0.033 4
Dibenzo[a,h]pyrene ‘‘ <0.067 4 <0.067 4 <0.067 4
Dibenzo[a,i]pyrene ‘‘ <0.050 4 <0.050 4 <0.050 4
Dibenzo[a,l]pyrene ‘‘ <0.031 4 <0.031 4 <0.031 4
5-Methylchrysene <0.025 4 <0.025 4 <0.025 4
Amines ‘‘
HMT lg/cig. 0.145 4 0.185 ± 0.019 4 0.358 ± 0.058 4
Metals
Cadmium ng/cig. 0.973 ± 0.114 3 <0.571 3 0.705 ± 0.094 3
Chromium ‘‘ <2.00 3 <1.43 3 <1.43 3
Nickel ‘‘ <4.00 3 <2.86 3 <2.86 3
Lead ‘‘ <4.00 3 <2.86 3 <2.86 3
Arsenic ‘‘ <2.00 3 <1.43 3 <1.43 3
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Table 4 (continued)
Parameter Unit EHCSS-K6 HIGH2L EHCSS-K6 HIGH2U EHCSS-K6 EXTREME
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.00 ± 0.00 8 8.00 ± 0.00 8 8.00 ± 0.00 8
TPM mg/cig. 10.8 ± 0.3 8 21.0 ± 0.4 8 20.9 ± 1.2 8
Tar ‘‘ 5.32 ± 0.11 8 11.3 ± 0.4 8 11.1 ± 1.0 8
Nicotine ‘‘ 0.444 ± 0.006 8 0.875 ± 0.031 8 0.928 ± 0.058 8
Water ‘‘ 5.02 ± 0.25 8 8.80 ± 0.33 8 8.86 ± 0.24 8
Carbon monoxide ‘‘ 0.440 ± 0.012 5 1.84 ± 0.14 5 2.87 ± 0.42 5
Aliphatic dienes
1,3-Butadiene lg/cig. 1.54 ± 0.14 4 6.98 ± 1.31 4 10.5 ± 1.7 4
Isoprene ‘‘ 31.7 ± 3.5 4 89.2 ± 12.5 4 122 ± 20 4
Aldehydes
Formaldehyde lg/cig. 40.2 ± 1.0 5 44.5 ± 1.4 7 46.7 ± 0.7 7
Acetaldehyde ‘‘ 216 ± 7 5 326 ± 11 7 373 ± 14 7
Acrolein ‘‘ 37.8 ± 1.7 5 54.9 ± 2.1 7 64.9 ± 2.2 7
Propionaldehyde ‘‘ 9.88 ± 0.65 5 14.9 ± 0.7 7 17.9 ± 0.8 7
Crotonaldehyde ‘‘ <5.50 5 <7.40 7 <7.40 7
Acid derivatives
Acetamide lg/cig. 2.10 ± 0.03 4 4.58 ± 0.32 4 5.08 ± 0.24 4
Acrylonitrile ‘‘ 0.812 ± 0.036 4 3.01 ± 0.54 4 4.03 ± 0.61 4
Nitro compounds
2-Nitropropane ng/cig. n.d. 11.9 ± 0.3 4 14.2 ± 0.4 4
Aromatic amines
o-Toluidine ng/cig. 1.61 ± 0.07 4 7.31 ± 0.60 7 7.18 ± 0.60 7
o-Anisidine ‘‘ 0.198 ± 0.003 4 0.550 ± 0.021 7 0.531 ± 0.021 7
2-Naphthylamine ‘‘ 0.134 ± 0.004 4 0.749 ± 0.075 7 0.773 ± 0.072 7
4-Aminobiphenyl ‘‘ 0.067 ± 0.001 4 0.261 ± 0.015 7 0.251 ± 0.014 7
Halogen compounds
Vinyl chloride ng/cig. <6.25 4 14.0 ± 1.0 4 15.6 ± 0.7 4
Inorganic compounds
Nitrogen oxides lg/cig. 32.5 ± 1.6 5 81.5 ± 3.3 5 94.2 ± 6.0 5
Hydrogen cyanide ‘‘ 10.8 ± 1.2 4 25.8 ± 1.1 4 36.0 ± 2.7 4
Ammonia ‘‘ 19.1 ± 0.4 4 28.9 ± 0.7 4 31.8 ± 1.5 4
Monocyclic aromatics
Benzene lg/cig. 0.488 ± 0.030 4 2.31 ± 0.56 4 3.46 ± 0.81 4
Toluene ‘‘ 1.69 ± 0.09 4 5.34 ± 0.88 4 7.22 ± 1.26 4
Styrene ‘‘ 0.317 ± 0.016 4 0.888 ± 0.137 4 1.19 ± 0.21 4
N-Nitrosamines
NNN lg/cig. 34.5 ± 0.9 4 61.6 ± 1.6 4 65.5 ± 0.7 4
NNK ‘‘ 8.86 ± 0.27 4 18.2 ± 0.4 4 20.1 ± 0.2 4
Phenols
Phenol lg/cig. 0.631 ± 0.019 4 2.75 ± 0.31 4 4.17 ± 0.57 4
Catechol ‘‘ 7.23 ± 0.10 4 21.3 ± 0.9 4 26.0 ± 1.8 4
PAHs
Pyrene ng/cig. 0.315 ± 0.035 4 2.34 ± 0.18 4 3.14 ± 0.66 4
Benz[a]anthracene ‘‘ 0.061 ± 0.005 4 0.676 ± 0.057 4 0.882 ± 0.180 4
Benzo[b]ﬂuoranthene ‘‘ 0.047 ± 0.003 4 0.344 ± 0.024 4 0.423 ± 0.073 4
Benzo[j]ﬂuoranthene ‘‘ <0.026 4 0.202 ± 0.016 4 0.254 ± 0.046 4
Benzo[k]ﬂuoranthene ‘‘ 0.021 4 0.134 ± 0.010 4 0.168 ± 0.031 4
Benzo[a]pyrene ‘‘ 0.052 ± 0.008 4 0.373 ± 0.028 4 0.493 ± 0.093 4
Indeno(1,2,3-cd)pyrene ‘‘ 0.036 ± 0.005 4 0.204 ± 0.014 4 0.259 ± 0.042 4
Dibenz[a,h]anthracene ‘‘ <0.034 4 <0.034 4 <0.034 4
Dibenzo[a,e]pyrene ‘‘ <0.033 4 <0.033 4 <0.033 4
Dibenzo[a,h]pyrene ‘‘ <0.067 4 <0.067 4 <0.067 4
Dibenzo[a,i]pyrene ‘‘ <0.050 4 <0.050 4 <0.050 4
Dibenzo[a,l]pyrene ‘‘ <0.031 4 <0.031 4 <0.031 4
5-Methylchrysene <0.025 4 <0.025 4 <0.025 4
Amines ‘‘
HMT lg/cig. 0.585 ± 0.092 4 0.385 ± 0.070 4 0.372 ± 0.011 4
Metals
Cadmium ng/cig. <0.500 3 2.90 ± 0.28 3 4.18 ± 0.16 3
Chromium ‘‘ <1.25 3 <2.50 3 <2.50 3
Nickel ‘‘ <2.50 3 <5.00 3 <5.00 3
Lead ‘‘ <2.50 3 <5.00 3 <5.00 3
Arsenic ‘‘ <1.25 3 <2.50 3 <2.50 3
Remarks: SE, standard error; N, number of determinations; n.d., not determined due to technical reasons.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 5
Yields from the EHCSS-K3 obtained under HPB conditions.
Parameter Unit EHCSS-K3 LOW EHCSS-K3 MED EHCSS-K3 HIGH EHCSS-K3 EXTREME
(mean ± SE) N (mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.00 ± 0.00 4 8.00 ± 0.00 4 8.00 ± 0.00 4 8.00 ± 0.00 4
TPM mg/cig. 3.25 ± 0.14 4 8.27 ± 0.16 4 14.1 ± 0.2 4 18.1 ± 0.7 4
Tar ‘‘ 1.76 ± 0.10 4 4.05 ± 0.16 4 7.76 ± 0.12 4 10.5 ± 0.9 4
Nicotine ‘‘ 0.095 ± 0.002 4 0.325 ± 0.007 4 0.497 ± 0.010 4 0.641 ± 0.019 4
Water ‘‘ 1.39 ± 0.05 4 3.90 ± 0.17 4 5.81 ± 0.05 4 6.99 ± 0.22 4
Carbon monoxide ‘‘ 0.373 ± 0.004 4 0.511 ± 0.012 7 0.756 ± 0.042 10 2.04 ± 0.27 10
Aliphatic dienes
1,3-Butadiene lg/cig. 1.67 ± 0.13 4 1.98 ± 0.09 4 3.63 ± 0.25 4 6.86 ± 0.50 4
Isoprene ‘‘ 42.5 ± 1.8 4 51.0 ± 1.5 4 77.6 ± 3.3 4 132 ± 4 4
Aldehydes
Formaldehyde lg/cig. 10.3 ± 0.4 5 22.5 ± 0.9 5 28.8 ± 0.9 5 30.8 ± 1.2 7
Acetaldehyde ‘‘ 130 ± 3 5 175 ± 6 5 231 ± 4 5 312 ± 13 7
Acrolein ‘‘ 13.6 ± 0.5 5 20.4 ± 0.9 5 28.5 ± 1.2 5 37.8 ± 2.2 7
Propionaldehyde ‘‘ 4.71 ± 0.14 5 7.00 ± 0.45 5 10.1 ± 0.3 5 16.1 ± 1.1 7
Crotonaldehyde ‘‘ <2.60 5 <2.60 5 2.73 5 3.73 7
Acid derivatives
Acetamide lg/cig. 0.160 ± 0.008 4 0.651 ± 0.024 4 1.31 ± 0.03 4 1.60 ± 0.04 4
Acrylonitrile ‘‘ 0.581 ± 0.038 4 0.843 ± 0.088 4 1.72 ± 0.20 4 3.07 ± 0.25 4
Nitro compounds
2-Nitropropane ng/cig. 3.48 ± 0.12 4 6.01 ± 0.32 4 5.56 ± 0.04 4 9.44 ± 0.32 4
Aromatic amines
o-Toluidine ng/cig. 0.165 ± 0.010 4 0.765 ± 0.031 4 1.80 ± 0.07 5 2.97 ± 0.38 7
o-Anisidine ‘‘ <0.137 4 0.148 ± 0.002 4 0.252 ± 0.007 5 0.337 ± 0.015 7
2-Naphthylamine ‘‘ <0.060 4 0.159 ± 0.008 4 0.337 ± 0.012 5 0.560 ± 0.053 7
4-Aminobiphenyl ‘‘ <0.044 4 0.080 ± 0.003 4 0.168 ± 0.003 5 0.239 ± 0.015 7
Halogen compounds
Vinyl chloride ng/cig. 8.93 ± 0.77 4 10.4 ± 1.8 4 17.7 ± 4.6 4 16.5 ± 2.5 4
Inorganic compounds
Nitrogen oxides lg/cig. 36.3 ± 0.5 4 52.2 ± 0.9 7 65.1 ± 1.9 10 94.3 ± 3.8 10
Hydrogen cyanide ‘‘ 4.79 ± 0.09 4 10.5 ± 0.5 4 22.1 ± 3.0 4 67.0 ± 15.6 4
Ammonia ‘‘ 6.48 ± 0.14 4 12.2 ± 0.5 4 16.8 ± 1.3 4 25.3 ± 0.5 4
Monocyclic aromatics
Benzene lg/cig. 0.352 ± 0.017 4 0.492 ± 0.012 4 1.21 ± 0.06 4 2.30 ± 0.08 4
Toluene ‘‘ 1.22 ± 0.04 4 1.72 ± 0.06 4 3.26 ± 0.15 4 5.35 ± 0.22 4
Styrene ‘‘ 0.136 ± 0.010 4 0.246 ± 0.002 4 0.497 ± 0.026 4 0.787 ± 0.022 4
N-Nitrosamines
NNN lg/cig. <7.80 4 26.1 ± 0.2 4 44.1 ± 0.7 4 51.5 ± 1.0 4
NNK ‘‘ 1.65 ± 0.08 4 7.00 ± 0.11 4 12.3 ± 0.2 4 15.0 ± 0.4 4
Phenols
Phenol lg/cig. 0.013 ± 0.004 4 0.012 ± 0.000 4 0.044 ± 0.006 4 0.053 ± 0.003 4
Catechol ‘‘ 1.35 ± 0.02 4 4.78 ± 0.08 4 9.21 ± 0.16 4 11.1 ± 0.2 4
PAHs
Pyrene ng/cig. <0.026 4 0.078 ± 0.005 4 1.04 ± 0.06 4 3.19 ± 0.23 4
Benz[a]anthracene ‘‘ 0.031 ± 0.002 3 0.104 ± 0.005 4 0.333 ± 0.016 4 1.12 ± 0.06 4
Benzo[b]ﬂuoranthene ‘‘ <0.022 3 0.064 ± 0.003 4 0.184 ± 0.007 4 0.547 ± 0.030 4
Benzo[j]ﬂuoranthene ‘‘ <0.021 3 0.037 ± 0.002 4 0.107 ± 0.007 4 0.331 ± 0.018 4
Benzo[k]ﬂuoranthene ‘‘ <0.021 3 0.026 ± 0.002 4 0.065 ± 0.003 4 0.201 ± 0.009 4
Benzo[a]pyrene ‘‘ 0.022 ± 0.002 3 0.077 ± 0.007 4 0.214 ± 0.008 4 0.655 ± 0.037 4
Indeno(1,2,3-cd)pyrene ‘‘ <0.013 3 0.043 ± 0.003 4 0.114 ± 0.004 4 0.343 ± 0.017 4
Dibenz[a,h]anthracene ‘‘ <0.034 3 <0.034 4 <0.034 4 0.064 ± 0.004 4
Dibenzo[a,e]pyrene ‘‘ <0.033 3 <0.033 4 <0.033 4 <0.033 4
Dibenzo[a,h]pyrene ‘‘ <0.067 3 <0.067 4 <0.067 4 <0.067 4
Dibenzo[a,i]pyrene ‘‘ <0.050 3 <0.050 4 <0.050 4 <0.050 4
Dibenzo[a,l]pyrene ‘‘ <0.031 3 <0.031 4 <0.031 4 <0.031 4
5-Methylchrysene <0.025 3 <0.025 4 <0.025 4 <0.025 4
Amines ‘‘
HMT lg/cig. <0.054 4 0.055 4 <0.107 4 <0.134 4
Metals
Cadmium ng/cig. <0.154 3 <0.400 3 1.06 ± 0.05 3 2.83 ± 0.30 3
Chromium ‘‘ <0.385 3 <1.00 3 <1.67 3 <2.00 3
Nickel ‘‘ <0.770 3 <2.00 3 <3.33 3 <4.00 3
Lead ‘‘ 5.48 ± 2.02 3 7.34 ± 1.38 3 21.3 3 5.31 ± 1.07 3
Arsenic ‘‘ <0.385 3 <1.00 3 <1.67 3 <2.00 3
Remarks: SE, standard error; N, number of determinations.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 6
Yields from the M6UK obtained under HPB conditions.
Parameter Unit M6UK LOW M6UK MED M6UK HIGH
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 14.1 ± 0.1 4 10.8 ± 0.0 4 10.6 ± 0.0 4
TPM mg/cig. 11.4 ± 0.2 4 19.3 ± 0.1 4 27.3 ± 0.4 4
Tar ‘‘ 9.44 ± 0.16 4 15.2 ± 0.1 4 20.1 ± 0.2 4
Nicotine ‘‘ 0.785 ± 0.018 4 1.19 ± 0.01 4 1.47 ± 0.02 4
Water ‘‘ 1.22 ± 0.01 4 2.87 ± 0.05 4 5.67 ± 0.23 4
Carbon monoxide ‘‘ 11.8 ± 0.2 4 19.4 ± 0.2 4 23.4 ± 0.4 4
Aliphatic dienes
1,3-Butadiene lg/cig. 24.0 ± 0.5 4 46.2 ± 1.0 4 64.2 ± 2.9 4
Isoprene ‘‘ 293 ± 3 4 552 ± 5 4 781 ± 21 4
Aldehydes
Formaldehyde lg/cig. 19.0 ± 0.2 5 47.9 ± 1.3 7 61.0 ± 1.3 9
Acetaldehyde ‘‘ 413 ± 4 5 859 ± 12 7 1120 ± 14 9
Acrolein ‘‘ 44.4 ± 0.7 5 97.4 ± 1.6 7 126 ± 2 9
Propionaldehyde ‘‘ 35.0 ± 0.5 5 72.3 ± 1.1 7 93.1 ± 1.3 9
Crotonaldehyde ‘‘ 5.68 ± 0.19 5 17.4 ± 0.3 7 25.0 ± 0.4 10
Acid derivatives
Acetamide lg/cig. 6.75 ± 0.11 4 11.8 ± 0.1 4 14.4 ± 0.4 4
Acrylonitrile ‘‘ 17.2 ± 0.4 4 31.7 ± 0.2 4 43.7 ± 1.2 4
Nitro compounds
2-Nitropropane ng/cig. 7.28 ± 0.21 4 14.3 ± 0.1 4 16.3 ± 0.4 4
Aromatic amines
o-Toluidine ng/cig. 54.0 ± 0.6 5 83.7 ± 1.9 5 96.0 ± 1.4 6
o-Anisidine ‘‘ 2.19 ± 0.04 5 3.36 ± 0.10 5 3.69 ± 0.06 6
2-Naphthylamine ‘‘ 7.46 ± 0.21 5 9.07 ± 0.23 5 9.65 ± 0.12 6
4-Aminobiphenyl ‘‘ 1.33 ± 0.05 5 2.06 ± 0.05 5 2.33 ± 0.05 6
Halogen compounds
Vinyl chloride ng/cig. 15.3 ± 0.5 4 25.7 ± 0.9 4 34.8 ± 2.2 4
Inorganic compounds
Nitrogen oxides lg/cig. 122 ± 2 4 198 ± 1 4 238 ± 4 4
Hydrogen cyanide ‘‘ 72.6 ± 1.9 4 83.7 ± 2.9 4 220 ± 16 4
Ammonia ‘‘ 9.81 ± 0.75 4 15.4 ± 0.5 4 20.0 ± 0.4 4
Monocyclic aromatics
Benzene lg/cig. 34.6 ± 0.2 4 57.4 ± 0.6 4 73.1 ± 1.7 4
Toluene ‘‘ 49.3 ± 0.4 4 96.9 ± 1.2 4 129 ± 3 4
Styrene ‘‘ 4.33 ± 0.12 4 11.3 ± 0.2 4 16.8 ± 0.4 4
N-Nitrosamines
NNN lg/cig. 49.3 ± 1.7 4 84.3 ± 2.5 4 100 ± 4 4
NNK ‘‘ 35.3 ± 1.3 4 57.0 ± 1.6 4 70.8 ± 3.1 4
Phenols
Phenol lg/cig. 10.2 ± 0.1 4 23.4 ± 0.4 4 19.1 ± 0.6 4
Catechol ‘‘ 44.5 ± 0.4 4 69.1 ± 0.9 4 83.2 ± 1.3 4
PAHs
Pyrene ng/cig. 47.4 ± 1.1 4 63.9 ± 0.9 4 78.3 ± 4.6 4
Benz[a]anthracene ‘‘ 14.1 ± 0.3 4 18.9 ± 0.3 4 21.8 ± 0.2 4
Benzo[b]ﬂuoranthene ‘‘ 7.06 ± 0.18 4 9.48 ± 0.22 4 11.2 ± 0.2 4
Benzo[j]ﬂuoranthene ‘‘ 4.33 ± 0.07 4 5.85 ± 0.09 4 6.79 ± 0.15 4
Benzo[k]ﬂuoranthene ‘‘ 2.86 ± 0.06 4 3.90 ± 0.17 4 4.61 ± 0.15 4
Benzo[a]pyrene ‘‘ 8.73 ± 0.21 4 11.8 ± 0.3 4 13.4 ± 0.2 4
Indeno(1,2,3-cd)pyrene ‘‘ 4.04 ± 0.15 4 5.45 ± 0.13 4 6.29 ± 0.10 4
Dibenz[a,h]anthracene ‘‘ <0.970 4 <0.970 4 1.02 ± 0.02 4
Dibenzo[a,e]pyrene ‘‘ 0.337 ± 0.008 4 0.467 ± 0.040 4 0.466 ± 0.024 4
Dibenzo[a,h]pyrene ‘‘ <0.200 4 <0.200 4 0.253 ± 0.024 4
Dibenzo[a,i]pyrene ‘‘ <0.200 4 <0.200 4 0.202 4
Dibenzo[a,l]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
5-Methylchrysene <0.400 4 <0.400 4 <0.400 4
Amines ‘‘
HMT lg/cig. 0.078 ± 0.002 4 0.157 ± 0.023 4 0.177 ± 0.005 4
Metals
Cadmium ng/cig. 26.0 ± 2.0 3 27.5 ± 0.5 3 32.0 ± 1.0 3
Chromium ‘‘ <1.00 3 <2.00 3 <3.33 3
Nickel ‘‘ <2.00 3 <4.00 3 <6.67 3
Lead ‘‘ 10.4 ± 1.4 3 24.1 ± 1.2 3 29.1 ± 2.6 3
Arsenic ‘‘ 2.37 ± 0.52 3 2.96 ± 0.08 3 4.71 ± 0.76 3
Remarks: SE, standard error; N, number of determinations.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 7
Yields from the M6J obtained under HPB conditions.
Parameter Unit M6J LOW M6J MED M6J HIGH
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 8.08 ± 0.10 4 7.65 ± 0.06 4 8.08 ± 0.05 4
TPM mg/cig. 2.79 ± 0.02 4 9.23 ± 0.06 4 15.2 ± 0.3 4
Tar ‘‘ 2.43 ± 0.04 4 7.52 ± 0.03 4 11.8 ± 0.1 4
Nicotine ‘‘ 0.168 ± 0.003 4 0.550 ± 0.007 4 0.850 ± 0.005 4
Water ‘‘ 0.198 ± 0.030 4 1.16 ± 0.02 4 2.63 ± 0.14 4
Carbon monoxide ‘‘ 3.01 ± 0.05 4 11.8 ± 0.2 4 17.4 ± 0.3 4
Aliphatic dienes
1,3-Butadiene lg/cig. 3.63 ± 0.15 4 18.2 ± 0.5 4 30.2 ± 0.3 4
Isoprene ‘‘ 28.3 ± 0.8 4 182 ± 6 4 323 ± 2 4
Aldehydes
Formaldehyde lg/cig. 2.75 ± 0.23 5 25.9 ± 1.6 5 41.2 ± 1.0 7
Acetaldehyde ‘‘ 42.0 ± 3.1 5 386 ± 19 5 674 ± 10 7
Acrolein ‘‘ 2.18 ± 0.16 5 32.9 ± 1.9 5 65.3 ± 1.2 7
Propionaldehyde ‘‘ 2.85 ± 0.24 5 29.1 ± 1.7 5 54.0 ± 0.8 7
Crotonaldehyde ‘‘ <2.10 5 3.1 ± 0.14 5 7.44 ± 0.15 7
Acid derivatives
Acetamide lg/cig. 0.825 ± 0.045 4 5.24 ± 0.07 4 8.61 ± 0.12 4
Acrylonitrile ‘‘ 1.67 ± 0.08 4 11.3 ± 0.4 4 19.5 ± 0.4 4
Nitro compounds
2-Nitropropane ng/cig. 1.34 ± 0.15 4 4.94 ± 0.27 4 8.45 ± 0.43 4
Aromatic amines
o-Toluidine ng/cig. 12.7 ± 0.5 4 45.2 ± 1.4 5 65.8 ± 1.9 6
o-Anisidine ‘‘ 0.565 ± 0.018 4 1.70 ± 0.04 5 2.43 ± 0.07 6
2-Naphthylamine ‘‘ 2.11 ± 0.1 4 5.34 ± 0.2 5 6.87 ± 0.35 6
4-Aminobiphenyl ‘‘ 0.372 ± 0.018 4 1.07 ± 0.05 5 1.40 ± 0.08 6
Halogen compounds
Vinyl chloride ng/cig. 4.30 ± 0.16 4 15.8 ± 0.3 4 25.9 ± 0.6 4
Inorganic compounds
Nitrogen oxides lg/cig. 41.4 ± 1.0 4 138 ± 2 4 196 ± 1 4
Hydrogen cyanide ‘‘ 3.29 ± 0.23 4 61.7 ± 2.1 4 114 ± 3 4
Ammonia ‘‘ 2.11 ± 0.09 4 6.37 ± 0.08 4 9.53 ± 0.20 4
Monocyclic aromatics
Benzene lg/cig. 2.39 ± 0.10 4 16.3 ± 0.2 4 27.1 ± 0.5 4
Toluene ‘‘ 2.94 ± 0.2 4 21.5 ± 0.5 4 38.6 ± 0.7 4
Styrene ‘‘ 0.138 ± 0.019 4 1.37 ± 0.04 4 3.00 ± 0.09 4
N-Nitrosamines
NNN lg/cig. 17.0 ± 0.4 4 48.0 ± 0.8 4 75.8 ± 1.7 4
NNK ‘‘ 13.5 ± 0.5 4 41.8 ± 1.6 4 64.3 ± 2.4 4
Phenols
Phenol lg/cig. 0.843 ± 0.012 4 7.35 ± 0.12 4 12.2 ± 0.2 4
Catechol ‘‘ 12.0 ± 0.2 4 36.1 ± 0.3 4 53.4 ± 0.5 4
PAHs
Pyrene ng/cig. 12.9 ± 0.2 4 34.6 ± 1.0 4 49.3 ± 1.1 4
Benz[a]anthracene ‘‘ 3.90 ± 0.07 4 10.7 ± 0.3 4 15.0 ± 0.4 4
Benzo[b]ﬂuoranthene ‘‘ 1.90 ± 0.02 4 5.13 ± 0.15 4 7.13 ± 0.2 4
Benzo[j]ﬂuoranthene ‘‘ 1.13 ± 0.02 4 3.08 ± 0.06 4 4.50 ± 0.14 4
Benzo[k]ﬂuoranthene ‘‘ 0.757 ± 0.02 4 2.06 ± 0.06 4 2.87 ± 0.11 4
Benzo[a]pyrene ‘‘ 2.47 ± 0.05 4 6.51 ± 0.23 4 9.10 ± 0.27 4
Indeno(1,2,3-cd)pyrene ‘‘ 1.14 ± 0.02 4 3.00 ± 0.08 4 4.18 ± 0.11 4
Dibenz[a,h]anthracene ‘‘ <0.970 4 <0.970 4 <0.970 4
Dibenzo[a,e]pyrene ‘‘ <0.200 4 0.235 ± 0.007 4 0.334 ± 0.006 4
Dibenzo[a,h]pyrene ‘‘ <0.200 4 <0.200 4 <0.202 4
Dibenzo[a,i]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,l]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
5-Methylchrysene <0.400 4 <0.400 4 <0.400 4
Amines ‘‘
HMT lg/cig. 0.015 ± 0.001 4 0.071 ± 0.002 4 0.105 ± 0.006 4
Metals
Cadmium ng/cig. 2.10 ± 0.30 3 7.83 ± 1.23 3 15.9 ± 0.6 3
Chromium ‘‘ <0.208 3 0.917 2 <1.67 3
Nickel ‘‘ 0.417 3 <1.67 2 <3.33 3
Lead ‘‘ 2.42 ± 0.21 3 11.9 ± 1.5 3 26.9 ± 0.8 3
Arsenic ‘‘ 0.421 ± 0.106 3 1.63 ± 0.19 3 2.59 ± 0.23 3
Remarks: SE, standard error; N, number of determinations.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 8
Yields from the PM1 obtained under HPB conditions.
Parameter Unit PM1 LOW PM1 MED PM1 HIGH
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 22.0 ± 0.0 4 17.5 ± 0.1 4 17.0 ± 0.2 4
TPM mg/cig. 5.36 ± 0.10 4 9.20 ± 0.14 4 13.0 ± 0.1 4
Tar ‘‘ 4.41 ± 0.09 4 7.83 ± 0.13 4 10.7 ± 0.1 4
Nicotine ‘‘ 0.454 ± 0.010 4 0.719 ± 0.013 4 0.956 ± 0.006 4
Water ‘‘ 0.501 ± 0.003 4 0.650 ± 0.020 4 1.35 ± 0.08 4
Carbon monoxide ‘‘ 6.48 ± 0.06 4 11.9 ± 0.2 4 11.0 ± 0.2 4
Aliphatic dienes
1,3-Butadiene lg/cig. 15.3 ± 0.8 4 31.5 ± 0.9 4 37.5 ± 0.8 4
Isoprene ‘‘ 210 ± 4 4 438 ± 5 4 566 ± 9 4
Aldehydes
Formaldehyde lg/cig. 5.61 ± 0.17 5 13.1 ± 0.4 5 14.0 ± 0.3 5
Acetaldehyde ‘‘ 223 ± 3 5 542 ± 12 5 735 ± 15 5
Acrolein ‘‘ 19.8 ± 0.3 5 50.3 ± 1.5 5 66.7 ± 2.0 5
Propionaldehyde ‘‘ 17.9 ± 0.1 5 45.2 ± 1.0 5 61.5 ± 1.4 5
Crotonaldehyde ‘‘ <2.10 5 8.99 ± 0.14 5 14.2 ± 0.1 5
Acid derivatives
Acetamide lg/cig. 1.81 ± 0.12 4 4.24 ± 0.14 4 6.01 ± 0.22 4
Acrylonitrile ‘‘ 11.3 ± 0.2 4 23.0 ± 0.5 4 29.1 ± 0.4 4
Nitro compounds
2-Nitropropane ng/cig. 4.55 ± 0.20 4 9.22 ± 0.23 4 14.1 ± 0.6 4
Aromatic amines
o-Toluidine ng/cig. 29.4 ± 0.9 4 54.4 ± 0.9 5 63.8 ± 1.0 5
o-Anisidine ‘‘ 1.48 ± 0.03 4 2.44 ± 0.07 5 2.76 ± 0.03 5
2-Naphthylamine ‘‘ 4.58 ± 0.23 4 6.83 ± 0.13 5 7.32 ± 0.18 5
4-Aminobiphenyl ‘‘ 0.830 ± 0.042 4 1.33 ± 0.03 5 1.46 ± 0.04 5
Halogen compounds
Vinyl chloride ng/cig. 9.87 ± 0.73 4 21.2 ± 0.5 4 25.0 ± 1.3 4
Inorganic compounds
Nitrogen oxides lg/cig. 99.0 ± 0.6 4 151 ± 2 4 139 ± 2 4
Hydrogen cyanide ‘‘ 21.7 ± 0.9 4 66.9 ± 3.2 4 112 ± 1 4
Ammonia ‘‘ 8.42 ± 0.62 4 6.61 ± 0.38 4 10.4 ± 0.4 4
Monocyclic aromatics
Benzene lg/cig. 17.6 ± 0.3 4 40.0 ± 0.5 4 51.8 ± 1.1 4
Toluene ‘‘ 32.9 ± 0.7 4 70.7 ± 1.2 4 95.2 ± 0.7 4
Styrene ‘‘ 2.59 ± 0.07 4 7.58 ± 0.19 4 11.1 ± 0.2 4
N-Nitrosamines
NNN lg/cig. 39.0 ± 1.2 4 56.5 ± 1.6 4 67.8 ± 3.1 4
NNK ‘‘ 26.0 ± 0.4 4 41.5 ± 3.6 4 50.8 ± 1.1 4
Phenols
Phenol lg/cig. 7.00 ± 0.31 4 13.8 ± 0.1 4 16.9 ± 0.2 4
Catechol ‘‘ 29.4 ± 0.6 4 44.9 ± 0.4 4 56.0 ± 0.6 4
PAHs
Pyrene ng/cig. 25.4 ± 0.4 4 38.0 ± 0.1 4 48.4 ± 0.6 4
Benz[a]anthracene ‘‘ 7.27 ± 0.07 4 10.9 ± 0.1 4 13.7 ± 0.3 4
Benzo[b]ﬂuoranthene ‘‘ 4.00 ± 0.05 4 5.89 ± 0.07 4 7.43 ± 0.10 4
Benzo[j]ﬂuoranthene ‘‘ 2.39 ± 0.03 4 3.51 ± 0.03 4 4.49 ± 0.09 4
Benzo[k]ﬂuoranthene ‘‘ 1.65 ± 0.03 4 2.39 ± 0.02 4 3.01 ± 0.04 4
Benzo[a]pyrene ‘‘ 4.54 ± 0.08 4 6.82 ± 0.08 4 8.54 ± 0.14 4
Indeno(1,2,3-cd)pyrene ‘‘ 2.15 ± 0.04 4 3.13 ± 0.05 4 3.90 ± 0.06 4
Dibenz[a,h]anthracene ‘‘ <0.970 4 <0.970 4 <0.970 4
Dibenzo[a,e]pyrene ‘‘ <0.200 4 0.261 ± 0.009 4 0.373 ± 0.009 4
Dibenzo[a,h]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,i]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,l]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
5-Methylchrysene <0.400 4 <0.400 4 <0.400 4
Amines ‘‘
HMT lg/cig. 0.030 4 0.060 ± 0.004 4 0.064 ± 0.002 4
Metals
Cadmium ng/cig. 7.87 ± 0.55 3 9.00 ± 0.12 3 9.24 ± 0.25 3
Chromium ‘‘ 0.75 3 <1.00 3 <1.43 3
Nickel ‘‘ <1.00 3 <2.00 3 <2.86 3
Lead ‘‘ 4.00 ± 0.29 3 7.27 ± 0.27 3 14.0 ± 2.6 3
Arsenic ‘‘ 0.653 ± 0.048 3 1.10 ± 0.05 3 1.68 ± 0.11 3
Remarks: SE, standard error; N, number of determinations.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 9
Yields from the Lark1 obtained under HPB conditions.
Parameter Unit Lark1 LOW Lark1 MED Lark1 HIGH
(mean ± SE) N (mean ± SE) N (mean ± SE) N
ISO parameters
Puff count – 22.2 ± 0.2 4 18.0 ± 0.2 4 16.3 ± 0.2 4
TPM mg/cig. 4.59 ± 0.18 4 6.36 ± 0.16 4 9.87 ± 0.29 4
Tar ‘‘ 3.91 ± 0.18 4 5.31 ± 0.14 4 8.05 ± 0.19 4
Nicotine ‘‘ 0.33 ± 0.01 4 0.459 ± 0.01 4 0.699 ± 0.02 4
Water ‘‘ 0.347 ± 0.02 4 0.588 ± 0.03 4 1.12 ± 0.09 4
Carbon monoxide ‘‘ 3.4 ± 0.1 4 6.82 ± 0.28 4 10.5 ± 0.3 4
Aliphatic dienes
1,3-Butadiene lg/cig. 11.8 ± 0.3 4 20.3 ± 2.0 4 35.2 ± 0.8 4
Isoprene ‘‘ 163 ± 2 4 254 ± 12 4 400 ± 7 4
Aldehydes
Formaldehyde lg/cig. 3.2 ± 0.18 5 5.4 ± 0.33 5 8.54 ± 0.26 5
Acetaldehyde ‘‘ 156 ± 5 5 256 ± 13 5 480 ± 8 5
Acrolein ‘‘ 9.65 ± 0.47 5 17.9 ± 1.3 5 40.2 ± 1.2 5
Propionaldehyde ‘‘ 11.5 ± 0.5 5 19.7 ± 1.1 5 38.8 ± 0.8 5
Crotonaldehyde ‘‘ <2.10 5 <2.10 5 3.61 ± 0.33 5
Acid derivatives
Acetamide lg/cig. 1.78 ± 0.05 4 3.08 ± 0.10 4 5.61 ± 0.2 4
Acrylonitrile ‘‘ 7.11 ± 0.18 4 11.9 ± 0.8 4 19.6 ± 0.6 4
Nitro compounds
2-Nitropropane ng/cig. 3.08 ± 0.32 4 5.23 ± 0.28 4 11.4 ± 0.7 4
Aromatic amines
o-Toluidine ng/cig. 22.2 ± 0.8 4 38.5 ± 1.9 4 56.5 ± 2.4 6
o-Anisidine ‘‘ 1.01 ± 0.07 4 1.64 ± 0.09 4 2.07 ± 0.09 6
2-Naphthylamine ‘‘ 4.22 ± 0.14 4 6.62 ± 0.35 4 8.01 ± 0.41 6
4-Aminobiphenyl ‘‘ 0.726 ± 0.030 4 1.17 ± 0.06 4 1.50 ± 0.07 6
Halogen compounds
Vinyl chloride ng/cig. 11.1 ± 0.4 4 18.1 ± 1.5 4 31.8 ± 1.0 4
Inorganic compounds
Nitrogen oxides lg/cig. 95.7 ± 2.1 4 165 ± 7 4 236 ± 4 4
Hydrogen cyanide ‘‘ 11.5 ± 0.8 4 28.0 ± 1.4 4 72.7 ± 4.0 4
Ammonia ‘‘ 3.26 ± 0.3 4 4.74 ± 0.12 4 6.90 ± 0.26 4
Monocyclic aromatics
Benzene lg/cig. 9.68 ± 0.35 4 15.8 ± 0.7 4 29.9 ± 1.0 4
Toluene ‘‘ 10.3 ± 0.5 4 16.5 ± 1.0 4 36.1 ± 1.5 4
Styrene ‘‘ 0.320 ± 0.038 4 0.460 ± 0.037 4 1.71 ± 0.12 4
N-Nitrosamines
NNN lg/cig. 56.5 ± 0.5 4 72.3 ± 1.7 4 101 ± 1 4
NNK ‘‘ 32.3 ± 0.9 4 40.3 ± 1.3 4 58.0 ± 0.8 4
Phenols
Phenol lg/cig. 2.54 ± 0.18 4 6.89 ± 0.17 4 13.3 ± 0.3 4
Catechol ‘‘ 17.4 ± 0.4 4 28.1 ± 0.5 4 39.4 ± 0.5 4
PAHs
Pyrene ng/cig. 20.4 ± 0.2 4 26.6 ± 0.1 4 38.2 ± 0.5 4
Benz[a]anthracene ‘‘ 6.79 ± 0.05 4 8.90 ± 0.16 4 13.3 ± 0.1 4
Benzo[b]ﬂuoranthene ‘‘ 2.87 ± 0.02 4 3.71 ± 0.02 4 5.28 ± 0.09 4
Benzo[j]ﬂuoranthene ‘‘ 1.78 ± 0.03 4 2.33 ± 0.03 4 3.35 ± 0.04 4
Benzo[k]ﬂuoranthene ‘‘ 1.09 ± 0.02 4 1.43 ± 0.02 4 1.98 ± 0.03 4
Benzo[a]pyrene ‘‘ 3.83 ± 0.03 4 5.03 ± 0.06 4 7.28 ± 0.08 4
Indeno(1,2,3-cd)pyrene ‘‘ 1.70 ± 0.01 4 2.21 ± 0.02 4 3.21 ± 0.03 4
Dibenz[a,h]anthracene ‘‘ <0.970 4 <0.970 4 <0.970 4
Dibenzo[a,e]pyrene ‘‘ <0.200 4 0.246 ± 0.016 4 0.389 ± 0.019 4
Dibenzo[a,h]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,i]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
Dibenzo[a,l]pyrene ‘‘ <0.200 4 <0.200 4 <0.200 4
5-Methylchrysene <0.400 4 <0.400 4 <0.400 4
Amines ‘‘
HMT lg/cig. 0.024 ± 0.003 4 0.033 ± 0.003 4 0.049 ± 0.001 4
Metals
Cadmium ng/cig. 3.82 ± 0.14 3 5.42 ± 0.22 3 8.83 ± 0.22 3
Chromium ‘‘ 0.377 ± 0.043 2 <0.625 3 <1.25 3
Nickel ‘‘ <0.667 2 <1.25 3 <2.50 3
Lead ‘‘ 2.31 ± 0.04 3 3.88 ± 0.22 3 10.0 ± 0.7 3
Arsenic ‘‘ 0.867 ± 0.102 3 1.31 ± 0.10 3 2.34 ± 0.25 3
Remarks: SE, standard error; N, number of determinations.
<: Median lower than the LOQ; in this case, the LOQ is given.
 At least 1 single value below the limit of quantitation (LOQ); in this case, the median or LOQ is reported without SE.
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Table 10
Cytotoxicity of TPM and GVP from EHCSS series-K and lit-end cigarettes obtained
under ISO smoking conditions.
Cigarette Yields [mg/cig.] Cytotoxicity (1/EC50a) [ml/cig.]
TPM Nicotine TPM GVP
(mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE)
EHCSS-K6 6.02 ± 0.25 0.329 ± 0.008 19.0 ± 1.4 25.0 ± 2.0
EHCSS-K6M 5.56 ± 0.17 0.262 ± 0.011 18.0 ± 2.1 27.8 ± 4.7
EHCSS-K3 2.86 ± 0.15 0.172 ± 0.011 10.7 ± 1.1 9.9 ± 0.5
M6UK 7.74 ± 0.28 0.538 ± 0.017 81.6 ± 5.0 59.8
M6J 8.38 ± 0.08 0.507 ± 0.009 85.5 ± 6.6 30.8 ± 3.0
PM1 1.83 ± 0.05 0.161 ± 0.006 17.8 ± 2.1 11.3
Lark1 1.44 ± 0.03 0.108 ± 0.003 13.4 ± 0.8 n.d.b
Remarks: SE, standard error.
a Mean reciprocal EC50 value of three batches (EC50 is the concentration that
reduces the number of viable cells by 50%, compared to untreated cells).
b Cytotoxicity could not be exactly determined up to the highest dose tested; 1/
EC50 value is below 3.1 ml/cig.
 Only results from two batches availabe; in this case, the reciprocal EC50 value is
reported without SE.
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minimize ‘‘toxicant-to-nicotine’’ ratios (Burns, 2006; Burns et al.,
2008; WHO Study Group on Tobacco Product Regulation, 2007,
2008).
5.1. ISO smoking conditions
Analytical data for HPHC obtained under ISO smoking condi-
tions are used by regulatory agencies for legislative action, such
as the 10 mg ‘tar ceiling’ in the European Community (European
Communities, 2001), and are a meaningful basis to provide a com-
mon basis for the comparison of cigarettes smoked under identical
conditions (Baker and Proctor, 2001), a comparison on the ‘product
level’. Since such comparisons directly examine and quantify dif-
ferences in exposure mass or yield and in toxicological response
of cigarettes, this information is valuable in terms of pre-clinical
evaluations, but not sufﬁcient for the substantiation of reducedTable 11
Cytotoxicity of TPM and GVP from EHCSS series-K and lit-end cigarettes obtained under H
Cigarette/smoking regimen Yields [mg/cig.]
TPM Nic
(mean ± SE) (me
EHCSS-K6 LOW4 8.59 ± 0.08 0.2
EHCSS-K6 MED1 8.43 ± 0.24 0.43
EHCSS-K6 MED2U 15.92 ± 0.18 0.67
EHCSS-K6 MED4 14.50 ± 0.14 0.5
EHCSS-K6 HIGH1 12.75 ± 0.39 0.7
EHCSS-K6 HIGH2L 10.78 ± 0.82 0.51
EHCSS-K6 HIGH2U 19.91 ± 0.76 0.92
EHCSS-K6 EXTREME 24.01 ± 0.85 1.05
EHCSS-K3 LOW 2.91 ± 0.41 0.08
EHCSS-K3 MED 8.29 ± 0.50 0.28
EHCSS-K3 HIGH 13.39 ± 0.38 0.5
EHCSS-K3 EXTREME 17.16 ± 0.27 0.61
M6UK LOW 11.69 ± 0.26 0.76
M6UK MED 19.43 ± 0.15 1.25
M6UK HIGH 28.20 ± 0.50 1.55
M6J LOW 2.75 ± 0.03 0.17
M6J MED 9.35 ± 0.13 0.5
M6J HIGH 15.03 ± 0.08 0.85
PM1 LOW 5.38 ± 0.12 0.46
PM1 MED 9.50 ± 0.17 0.71
PM1 HIGH 12.94 ± 0.13 0.93
Lark1 LOW 4.63 ± 0.28 0.34
Lark1 MED 6.78 ± 0.36 0.48
Lark1 HIGH 10.04 ± 0.24 0.75
Remarks: SE, standard error.
a Mean reciprocal EC50 value of three batches (EC50 is the concentration that reduces
 Only results from two batches availabe; in this case, the reciprocal EC50 value is reporexposure, because the way people smoke has a major impact on
the formation of and the exposure to toxicants, i.e., requires at a
minimum a comparison on the ‘smoker level’.
5.2. HPB conditions
Smokers smoke differently from one another and vary their
smoking patterns by altering puff volume, puff duration, and puff
frequency as well as by blocking of ventilation holes on the
cigarette, thus affecting smoke delivery and exposure. These smok-
ing topography parameter have been described to be important
variables in cigarette smoking and thus to be important determi-
nants of total smoke yield and intake (Fischer et al., 1989; Scherer,
1999). To account for the broad spectrum of human pufﬁng behav-
ior, 25 different HPB conditions were applied. Smoking topography
data and nicotine uptake distributions determined in a clinical
study were used to derive smoking machine settings delivering
mainstream smoke yields consistent with human pufﬁng behavior,
introducing a comparison on the ‘smoker level’. In general, an in-
crease in pufﬁng intensity was associated with an increase in HPHC
yields as well as with an increase in total cytotoxicity and total
bacterial mutagenicity of mainstream smoke for both the EHCSS
series-K and the conventional lit-end cigarettes.
When applying the same puff volume and puff frequency to the
EHCSS series-K cigarettes (e.g., comparisons of EHCSS-K6 MED2L to
EHCSS-K6 MED2U, EHCSS-K6 HIGH2L to EHCSS-K6 HIGH2U, or
EHCSS-K3 HIGH to EHCSS-K3 EXTREME), an increase in puff dura-
tion results in an increase of mainstream smoke HPHC yields
which was reﬂected by an increase in cytotoxicity of TPM and
GVP as well as by increased bacterial mutagenicity of TPM.
The inﬂuence of puff frequency on the delivery of HPHC and the
toxicological activity of mainstream smoke from the EHCSS-K6 can
be seen when comparing EHCSS-K6 MED4 to EHCSS-K6 MED1. The
4-fold increase in puff frequency also resulted in an increase in the
deliveryofHPHC.Again, thiswas reﬂectedby increases incytotoxicity
of TPMandGVPaswell as inbacterialmutagenicity of TPM.However,PB conditions.
Cytotoxicity (1/EC50a) [ml/cig.]
otine TPM GVP
an ± SE) (mean ± SE) (mean ± SE)
02 ± 0.002 12.0 ± 0.2 26.8 ± 1.6
2 ± 0.008 18.3 ± 0.3 25.3 ± 1.5
9 ± 0.004 36.1 ± 1.4 40.0 ± 1.6
04 ± 0.013 24.3 ± 1.2 33.8 ± 1.7
07 ± 0.014 36.6 ± 2.5 39.4 ± 3.8
3 ± 0.034 26.1 ± 3.6 36.1 ± 2.5
7 ± 0.011 68.7 ± 4.6 71.8 ± 4.9
7 ± 0.032 86.4 ± 1.0 88.1 ± 11.6
4 ± 0.004 6.6 ± 0.3 9.7 ± 0.5
3 ± 0.003 15.0 ± 0.9 21.1 ± 1.5
02 ± 0.009 28.2 ± 0.8 26.9 ± 4.4
3 ± 0.017 39.1 ± 1.8 44.3 ± 4.5
5 ± 0.012 126.1 ± 3.1 63.8 ± 3.5
4 ± 0.034 197.7 ± 2.9 147.1 ± 5.3
9 ± 0.033 258.9 ± 8.2 208.9 ± 15.4
8 ± 0.006 31.2 ± 1.0 4.3 ± 0.2
70 ± 0.007 100.8 ± 2.8 43.3 ± 1.5
4 ± 0.010 158.5 ± 7.3 79.7 ± 1.2
9 ± 0.007 64.3 ± 2.0 30.4 ± 1.2
4 ± 0.037 107.3 ± 7.7 67.9 ± 2.3
3 ± 0.009 141.4 ± 2.8 103.2 ± 4.7
7 ± 0.014 53.4 ± 3.3 15.7
1 ± 0.017 69.0 ± 4.1 24.6 ± 5.1
1 ± 0.015 112.9 ± 3.9 53.1 ± 2.6
the number of viable cells by 50%, compared to untreated cells).
ted without SE.
Fig. 1. Cytotoxicity of GVP from the EHCSS-K6 cigarette and the Reference Cigarette 2R4F smoked under ISO conditions and the EHCSS-K6 cigarette smoked under HPB
conditions (mean ± SE).
Table 12
Bacterial mutagenicity of TPM from EHCSS series-K and lit-end cigarettes obtained under ISO smoking conditions.
Cigarette Yields [mg/cig.] Mutagenicitya [revertants/cig.]
With S9 Without S9
TPM Nicotine TA98 TA100 TA1537 TA98 TA100 TA1537
M M (mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE)
EHCSS-K6 6.02 0.334 739 ± 41 481 ± 75 131 ± 17 27 ± 6 234 ± 39 32 ± 3
EHCSS-K6M 5.29 0.255 594 ± 38 591 ± 27 134 ± 29 36 ± 4 170 ± 34 40 ± 5
EHCSS-K3 3.26 0.181 450 ± 26 343 ± 31 93 ± 8 23 ± 3 133 ± 24 23 ± 2
M6UK 8.17 0.563 18,141 ± 595 9646 ± 854 3137 ± 278 107 ± 25 590 ± 225 112 ± 21
M6J 8.17 0.512 18,593 ± 614 9598 ± 814 3401 ± 363 47 ± 21 795 ± 179 48 ± 24
PM1 1.78 0.161 4725 ± 160 2131 ± 191 786 ± 72 9 ± 4 178 ± 49 22 ± 4
Lark1 1.39 0.103 3738 ± 133 1626 ± 143 699 ± 69 6 ± 2 104 ± 40 13 ± 3
Remarks: SE, standard error.
a Regression coefﬁcient ± SE over two batches, N = 18 plates.
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pared to those solely induced by increases in puff duration.
A conclusive evaluation regarding the impact of puff volume on
the delivery of HPHC and the toxicological activity of the EHCSS-
K6 could only be derived when comparing the data obtained for
the HPB conditions of EHCSS-K6 MED1 to those for the ISO condi-
tions,where the samepuff frequencyandalmost the samepuff dura-
tion (1.8 s and 2.0 s, respectively) were applied. The increase in puff
volume also resulted in a less pronounced increase in the delivery of
HPHC. However, this increase in puff volume did not result in differ-
ences in the cytotoxic activity of TPMandGVP, and also the bacterial
mutagenicity of TPMwas similar under the two sets of smoking con-
ditions. Thus, changes in puff duration are shown to have the largest
impact on the delivery of HPHC and the toxicological activity of TPM
and GVP followed by changes in puff frequency and puff volume.
It is known that alterations in pufﬁng conditionsmay change the
burning temperature and consequently inﬂuence the relative yields
of tobacco combustion products due to the generation of new com-
ponents or results in the disappearance of some components iden-
tiﬁed under standard smoking conditions. The toxicological activity
of smoke is thus altered accordingly (Eberhardt and Scherer, 1995;
Rustemeier et al., 2000). The NRU assay is capable of detecting bothchanges in cigarette smoke that may impact its irritant potential
(Andreoli et al., 2003) and increases in aldehyde concentrations,
especially of acrolein (Putnam et al., 2002). The bacterial mutage-
nicity of cigarette smoke as assessed in the Ames assay is known
to correlate well with the yields of aromatic amines and PAHs (Hak-
ura et al., 2005). It is also known from previous studies on EHCSS
cigarettes that the use of more intense alternative pufﬁng condi-
tions (compared to ISO smoking conditions) results in increased
yields of HPHC as well as in increased cytotoxicity of mainstream
smoke and bacterial mutagenicity of TPM on a per cigarette basis
(Roemer et al., 2004; Werley et al., 2008). However, when compar-
ing the EHCSS series-K and the conventional lit-end cigarettes all
smoked under the most intense HPB conditions for each cigarette,
the yields of HPHC as well as the cytotoxicity of mainstream smoke
and the bacterial mutagenicity of TPM were generally lower for the
EHCSS series-K cigarettes, even though the puff volumeswere high-
er and the puff durations were longer. Due to the fact that the GVP
was not tested in the plate incorporation version of the Ames assay,
the mutagenic potential of HPHC partly or predominantly present
in the GVP could not be comprehensively reﬂected by the data re-
ported in this manuscript. Some of these HPHC such as formalde-
hyde, acrolein, and crotonaldehyde have been described as key
Table 13
Bacterial mutagenicity of TPM from EHCSS series-K and lit-end cigarettes obtained under HPB conditions.
Cigarette/smoking regimen Yields [mg/cig.] Mutagenicitya [revertants/cig.]
With S9 Without S9
TPM Nicotine TA98 TA100 TA1537 TA98 TA100 TA1537
M M (mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE) (mean ± SE)
EHCSS-K6 LOW4 8.79 0.194 389 ± 50 364 ± 84 105 ± 23 19 ± 4 5b ± 51 26 ± 5
EHCSS-K6 MED1 9.16 0.425 497 ± 96 307 ± 100 146 ± 26 38 ± 8 217 ± 54 40 ± 6
EHCSS-K6 MED2L 4.85 0.145 188 ± 24 13b ± 56 28 ± 11 10 ± 3 102 ± 24 19 ± 4
EHCSS-K6 MED2U 17.31 0.684 2310 ± 100 1171 ± 181 417 ± 43 59 ± 14 508 ± 113 72 ± 8
EHCSS-K6 MED4 13.83 0.485 869 ± 89 583 ± 136 208 ± 40 44 ± 9 191b ± 89 47 ± 5
EHCSS-K6 HIGH1 12.54 0.668 1436 ± 89 607 ± 158 227 ± 31 59 ± 9 270b ± 87 53 ± 9
EHCSS-K6 HIGH2L 9.06 0.480 607 ± 50 305 ± 86 123 ± 23 37 ± 6 155 ± 58 49 ± 7
EHCSS-K6 HIGH2U 21.08 0.907 3823 ± 161 2273 ± 194 594 ± 71 97 ± 19 365 ± 101 99 ± 11
EHCSS-K6 EXTREME 22.36 1.021 5056 ± 299 2362 ± 244 1032 ± 78 118 ± 14 694 ± 164 168 ± 17
EHCSS-K3 LOW 2.76 0.074 258 ± 24 154 ± 28 44 ± 7 13 ± 2 58 ± 17 16 ± 1
EHCSS-K3 MED 8.10 0.290 831 ± 54 399 ± 85 123 ± 17 30 ± 4 247 ± 71 28 ± 6
EHCSS-K3 HIGH 13.50 0.504 1673 ± 108 1207 ± 88 314 ± 40 48 ± 7 186b ± 80 52 ± 8
EHCSS-K3 EXTREME 17.51 0.620 3549 ± 147 2130 ± 174 716 ± 85 77 ± 11 593 ± 115 85 ± 8
M6UK LOW 11.67 0.839 24,591 ± 739 14,130 ± 564 4548 ± 683 99 ± 27 836 ± 209 219 ± 21
M6UK MED 19.04 1.277 34,911 ± 1280 20,712 ± 1511 6477 ± 786 292 ± 40 2044 ± 278 221 ± 34
M6UK HIGH 26.36 1.632 43,305 ± 1613 22,606 ± 1620 9020 ± 862 317 ± 63 1943 ± 448 269 ± 38
M6J LOW 2.71 0.183 5823 ± 252 3416 ± 197 990 ± 136 27 ± 8 297 ± 56 17 ± 4
M6J MED 9.06 0.590 16,384 ± 678 9546 ± 486 2880 ± 359 104 ± 29 707 ± 146 137 ± 18
M6J HIGH 14.69 0.905 23,224 ± 1150 14,527 ± 714 4043 ± 784 177 ± 54 1323 ± 243 186 ± 30
PM1 LOW 5.56 0.498 13,599 ± 521 6980 ± 537 2611 ± 181 48 ± 15 561 ± 103 65 ± 13
PM1 MED 9.20 0.804 23,058 ± 1034 11,880 ± 728 3854 ± 281 146 ± 24 932 ± 144 100 ± 40
PM1 HIGH 13.18 1.045 30,838 ± 1311 16,779 ± 1105 5218 ± 474 101 ± 29 1246 ± 191 198 ± 54
Lark1 LOW 4.94 0.397 13,432 ± 366 6753 ± 503 2535 ± 299 49 ± 15 321 ± 81 36 ± 10
Lark1 MED 6.58 0.523 19,041 ± 472 8501 ± 466 3403 ± 249 33 ± 20 691 ± 103 83 ± 13
Lark1 HIGH 10.32 0.791 27,446 ± 1069 12,446 ± 835 4017 ± 742 129 ± 29 889 ± 144 104 ± 23
Remarks: SE, standard error.
a Regression coefﬁcient ± SE over two batches, N = 18 plates.
b Regression coefﬁcient not signiﬁcantly different from 0 for both batches.
Fig. 2. Bacterial mutagenicity (strain TA98 with S9 activation) of TPM from the EHCSS-K6 cigarette and the Reference Cigarette 2R4F smoked under ISO conditions and from
the EHCSS-K6 cigarette smoked under HPB conditions (mean ± SE).
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rettes (Weber et al., 2010) and both formaldehyde and acrolein, but
not crotonaldehyde, are present in the mainstream smoke of EHCSS
series-K cigarettes.
5.3. HPHC/toxicity parameter-to-nicotine regressions
The purpose of using 25 HPB conditions in addition to the ISO
data was to establish HPHC-to-nicotine regressions (or in vitro
toxicity-to-nicotine regressions), as depicted in Figs. 3–10. The
intercept, slope, and coefﬁcient of determination (r2) for the ciga-
rettes used for the ‘nicotine bridging method’ are reported in Urban
et al. (2012).The EHCSS is designed to generate an aerosol by heating the
tobacco at lower temperatures than the temperature generated
in CC, which results in a strong reduction in pyrolysis and com-
bustion products (Schorp et al., 2012). In general, some HPHC
are generated at lower temperatures (e.g., aldehydes), while
some HPHC are generated at higher temperatures (e.g., the
PAHs) (Torikai et al., 2005). About 45% of the HPHC/toxicity
parameter-to-nicotine relationships were better described by
non-linear equations. In other words, the exponential release of
several compounds (in particular the PAHs) indicated a change
in aerosol formation due to beginning or advanced pyrolysis
and/or combustion under the most intense smoking conditions
for the EHCSS (Urban et al., 2012). This hypothesis was sup-
Fig. 3. Correlation of acrolein and nicotine obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions.
Fig. 4. Correlation of carbon monoxide and nicotine obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions.
Fig. 5. Correlation of benzene and nicotine obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions.
S30 V. Zenzen et al. / Regulatory Toxicology and Pharmacology 64 (2012) S11–S34
Fig. 6. Correlation of pyrene and nicotine obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions.
Fig. 7. Correlation of 4-aminobiphenyl and nicotine obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions.
Fig. 8. Cytotoxicity of TPM obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions vs. nicotine yield.
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Fig. 9. Cytotoxicity of GVP obtained from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions vs. nicotine yield.
Fig. 10. Bacterial mutagenicity (strain TA98 with S9 activation) of TPM obtained
from EHCSS series-K and lit-end cigarettes under ISO smoking and HPB conditions
vs. nicotine yield.
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HPB conditions only.
For CC, the majority of HPHC as well as all toxicological end-
points determined showed a strong linear relationship with nico-
tine yields. A very strong linear correlation was found for tar,
conﬁrming observations reported by Counts et al. (2004). Weaker
linear correlations for NNN and NNK (Urban et al., 2012) might
be due to the fact that the concentration of precursors in the blend
is a limiting factor for their release during combustion. HPHC such
as tobacco-speciﬁc nitrosamines are mostly distilled from the to-
bacco during smoking.6. Conclusion
The analytical results demonstrate that mainstream smoke
from EHCSS is distinctly different from that of CC. With very few
exceptions, EHCSS demonstrate a substantial reduction in the tox-
icological activity of mainstream smoke compared to CC whensmoked with comparable pufﬁng intensities or to comparable nic-
otine yields.
Based on overall weight-of-evidence from pre-clinical and clin-
ical evaluations of EHCSS, the product design could reasonably be
expected to not increase or change the hazard compared to CC,
and that smoking of EHCSS results in substantially reduced expo-
sure to HPHC compared to smoking of CC. Employing a variety of
human pufﬁng behavior conditions (in this case 25) in addition
to the ISO smoking conditions enables a more rigorous examina-
tion of the relative performance of these products which repre-
sents one necessary step in the heuristic for reduced exposure
substantiation in a translational fashion – from ‘product’ to ‘smo-
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